https://thepharmanavigator.com/news/agilent-completes-acquisition-of-biovectra-to-expand-cdmo-capabilities/2024-09-25T09:10:00+00:00https://thepharmanavigator.com/news/ai-designed-universal-coronavirus-vaccine-passes-first-human-trial/2026-06-09T14:06:19+00:00https://thepharmanavigator.com/news/ai-study-expands-potential-for-glp-1-use-in-cardiovascular-care/2024-10-21T14:40:00+00:00https://thepharmanavigator.com/news/aizon-secures-20m-for-ai-based-pharma-manufacturing-and-next-gen-electronic-batch-record-systems/2024-02-22T09:25:00+00:00https://thepharmanavigator.com/news/ajinomoto-to-lay-off-71-employees-as-it-streamlines-cdmo-business/2024-08-16T13:38:00+00:00https://thepharmanavigator.com/news/akari-therapeutics-and-peak-bio-announce-merger/2024-03-22T13:56:00+00:00https://thepharmanavigator.com/news/astrazenecas-tagrisso-receives-chemotherapy-fda-approval/2024-03-07T15:28:00+00:00https://thepharmanavigator.com/news/autolomous-and-cellular-origins-target-cell-therapy-scale-up-challenges-with-partnership/2026-07-17T11:48:16+00:00https://thepharmanavigator.com/news/bioage-raises-170-million-to-develop-new-obesity-therapies/2024-02-29T10:40:00+00:00https://thepharmanavigator.com/news/biocina-and-novacina-merge-to-strengthen-australian-cdmo-industry/2025-02-01T10:52:00+00:00https://thepharmanavigator.com/news/bioduro-and-sgx-partner-up-to-improve-efficiencies-in-complex-drug-development/2025-06-16T15:31:33+00:00https://thepharmanavigator.com/news/bora-completes-acquisition-of-us-based-upsher-smith/2024-04-16T13:38:00+00:00https://thepharmanavigator.com/news/bora-pharmaceutical-ceo-backs-innovate-taiwan-program/2024-05-16T14:39:09+00:00https://thepharmanavigator.com/news/bora-pharmaceuticals-expands-rare-disease-reach-with-pyros-pharmaceuticals-acquisition/2024-11-09T13:49:00+00:00https://thepharmanavigator.com/news/bora-pharmaceuticals-to-acquire-us-pharma-manufacturer-upsher-smith/2024-01-30T10:43:00+00:00https://thepharmanavigator.com/news/breaking-through-the-bitterness-bottleneck/2026-07-08T15:38:18+00:00https://thepharmanavigator.com/news/breakthrough-in-pulmonary-fibrosis-treatment-gri-bios-promising-preclinical-results/2024-05-29T08:38:00+00:00https://thepharmanavigator.com/news/catalent-wins-supply-chain-management-award-for-cell-gene-therapy-initiative/2023-11-01T10:13:00+00:00https://thepharmanavigator.com/news/cber-issues-rtf-for-modernas-investigational-flu-shot/2026-02-11T10:07:01+00:00https://thepharmanavigator.com/news/cdmo-forms-strategic-collaborations-for-cell-based-therapies-in-eye-disease-and-solid-tumors/2025-05-28T08:29:58+00:00https://thepharmanavigator.com/news/cordenpharma-to-invest-900-million-to-meet-glp-1-drug-demand/2024-07-16T08:28:00+00:00https://thepharmanavigator.com/news/could-cdmos-replace-the-need-for-biopharma-incubators/2024-11-28T09:05:00+00:00https://thepharmanavigator.com/news/when-will-ai-solve-the-drug-discovery-challenge/2024-05-17T08:51:00+00:00https://thepharmanavigator.com/news/why-small-molecule-products-are-still-important/2025-02-04T15:17:47+00:00https://thepharmanavigator.com/news/wilmington-pharmatech-secures-major-investment-to-accelerate-expansion/2025-11-11T20:44:00+00:00https://thepharmanavigator.com/news/wuxi-biologics-withdraws-from-2024-bio-convention-amid-geopolitical-tensions/2024-05-28T14:50:00+00:00https://thepharmanavigator.com/news/zealand-pharma-announces-obesity-success-with-liver-disease-treatment/2024-03-11T09:57:00+00:00https://thepharmanavigator.com/news/10-year-high-for-biotech-bankruptcies/2024-02-26T10:19:00+00:00https://thepharmanavigator.com/news/2024-nobel-prize-in-physiology-or-medicine-awarded-for-discovery-of-microrna/2024-10-22T14:47:00+00:00https://thepharmanavigator.com/news/2024-pharma-job-loss-announcements/2024-03-20T09:28:00+00:00https://thepharmanavigator.com/news/23andme-shuts-down-drug-discovery-group-shifts-to-personalized-glp-1-weight-loss/2024-08-15T13:30:00+00:00https://thepharmanavigator.com/news/3p-innovation-launches-generic-next-gen-dpi-filling-technology/2025-05-02T15:07:23+00:00https://thepharmanavigator.com/news/a-modular-revolution-in-biomanufacturing/2026-04-28T11:18:44+00:00https://thepharmanavigator.com/news/a-new-era-for-excipients-key-takeaways-from-the-ipec-europe-excipients-forum-2026/2026-03-31T09:10:58+00:00https://thepharmanavigator.com/news/a-new-era-for-large-molecule-biomanufacturing-insights-from-the-cphi-frankfurt-2025-digital-event/2025-11-04T14:48:00+00:00https://thepharmanavigator.com/news/a-rapid-evolution-highlights-and-insights-from-advancing-complex-biologics-day-2025/2025-06-19T15:39:59+00:00https://thepharmanavigator.com/news/a-second-wave-of-renaissance-insights-from-cphi-frankfurt-2025-digital-event/2025-11-04T11:12:00+00:00https://thepharmanavigator.com/news/a-strategic-lever-the-new-role-for-cdmos-in-the-innovative-age/2025-10-15T17:42:00+00:00https://thepharmanavigator.com/news/abbvie-acquires-immunogen-for-oncology-pipeline/2024-02-22T15:04:00+00:00https://thepharmanavigator.com/news/abbvie-and-gilgamesh-collaborate-on-psychiatric-disorder-therapies/2024-05-26T10:25:00+00:00https://thepharmanavigator.com/news/abbvie-announces-new-ceo-bond-sell-off-and-ose-immunotherapeutics-deal/2024-03-07T10:07:00+00:00https://thepharmanavigator.com/news/abbvie-remegen-sign-exclusive-licensing-agreement-for-novel-bispecific-antibody/2026-01-14T16:25:18+00:00https://thepharmanavigator.com/news/abbvie-targets-obesity-market-with-novel-drug/2026-03-13T15:58:42+00:00https://thepharmanavigator.com/news/abbvies-qulipta-shows-long-term-promise-for-migraine-prevention/2024-04-30T10:19:00+00:00https://thepharmanavigator.com/news/abzena-and-argonaut-partner-to-promise-accelerated-drug-development-support/2024-07-08T07:58:00+00:00https://thepharmanavigator.com/news/accord-healthcare-secures-investment-to-boost-medicine-manufacturing-in-the-uk/2024-11-22T10:11:00+00:00https://thepharmanavigator.com/news/accure-therapeutics-granted-usd16-million-to-advance-parkinsons-drug-candidate/2025-04-15T08:18:00+00:00https://thepharmanavigator.com/news/actigraph-expands-digital-health-portfolio-with-biofourmis-life-science-business/2025-01-10T08:39:00+00:00https://thepharmanavigator.com/news/actively-working-to-enhance-biomanufacturings-digital-maturity/2025-08-20T14:52:00+00:00https://thepharmanavigator.com/news/activist-investors-eyeing-big-pharma-what-it-means-for-the-industry/2024-11-06T11:49:05+00:00https://thepharmanavigator.com/news/adapting-to-an-expedited-review-process/2025-07-09T14:45:00+00:00https://thepharmanavigator.com/news/adare-adds-to-high-potency-capabilities-in-europe-and-the-us/2024-05-06T09:56:00+00:00https://thepharmanavigator.com/news/adare-and-laxxon-medical-partner-to-expand-3d-printed-drug-manufacturing/2024-10-02T10:11:00+00:00https://thepharmanavigator.com/news/adare-collaborate-with-laxxon-to-add-3d-printing-from-milan-facility/2024-09-30T12:10:00+00:00https://thepharmanavigator.com/news/adare-expands-european-packaging-and-warehousing-capabilities/2025-11-03T11:57:00+00:00https://thepharmanavigator.com/news/adare-moves-its-headquarters-from-new-jersey-to-philadelphia/2024-10-06T10:51:00+00:00https://thepharmanavigator.com/news/adare-pharma-solutions-expands-in-pennsylvania-welcomes-governor-shapiro/2025-01-22T08:17:00+00:00https://thepharmanavigator.com/news/adare-pharma-solutions-to-expand-oral-dose-packaging-and-warehousing-capabilities-in-europe/2024-03-27T10:43:00+00:00https://thepharmanavigator.com/news/adragos-pharma-and-towa-partner-up-to-boost-supply-of-off-patent-drugs/2026-07-03T15:28:45+00:00https://thepharmanavigator.com/news/adragos-pharma-expands-global-footprint-with-swiss-acquisition/2024-12-24T10:49:00+00:00https://thepharmanavigator.com/news/adragos-pharma-expands-sterile-manufacturing-prowess-with-swiss-acquisition/2024-12-06T15:31:00+00:00https://thepharmanavigator.com/news/adragos-significantly-increases-japanese-capacity/2025-03-30T15:41:00+00:00https://thepharmanavigator.com/news/aenova-expands-high-potency-development-manufacturing-capabilities/2024-10-03T10:19:28+00:00https://thepharmanavigator.com/news/aenova-expands-production-with-usd-22-million-investment/2025-03-20T11:56:03+00:00https://thepharmanavigator.com/news/afton-scientific-plans-200m-plant-expansion-200-new-jobs/2024-10-16T14:01:00+00:00https://thepharmanavigator.com/news/afton-scientific-to-invest-200-million-on-facility-expansion/2024-11-05T14:08:00+00:00https://thepharmanavigator.com/news/agc-biologics-to-let-go-of-100-employees-amid-post-pandemic-woes/2024-05-18T10:38:00+00:00https://thepharmanavigator.com/news/agc-pauses-cgt-operations/2024-11-01T13:55:00+00:00https://thepharmanavigator.com/news/agenus-pivots-to-cdmo-services-amid-regulatory-setbacks/2024-12-22T10:13:00+00:00https://thepharmanavigator.com/news/agilent-to-acquire-biovectra-and-expand-biopharma-solutions/2024-07-30T12:29:00+00:00https://thepharmanavigator.com/news/alcami-appoints-tori-e-arens-as-president-of-drug-product/2025-02-21T07:43:00+00:00https://thepharmanavigator.com/news/alcami-establishes-transatlantic-footprint-with-tjoapack-acquisition/2026-04-28T15:32:44+00:00https://thepharmanavigator.com/news/alcami-expands-pharma-storage-capabilities-in-garner/2024-08-01T13:17:00+00:00https://thepharmanavigator.com/news/alcami-meets-demand-for-parenteral-manufacturing-with-new-rtp-and-charleston-fill-finish-capacity/2024-06-06T06:40:00+00:00https://thepharmanavigator.com/news/alcami-strengthens-tennessee-site-after-tjoapack-acquisition/2026-06-29T15:30:50+00:00https://thepharmanavigator.com/news/alliance-forms-to-automate-cell-and-gene-therapy-manufacturing/2026-03-22T15:43:47+00:00https://thepharmanavigator.com/news/almac-groups-65m-investment-in-northern-ireland-manufacturing-facility/2025-03-21T11:58:00+00:00https://thepharmanavigator.com/news/altrubio-secures-series-b-funding-for-autoimmune-regulator/2024-06-09T08:28:00+00:00https://thepharmanavigator.com/news/amgen-further-commits-to-us-manufacturing-with-ohio-investment/2025-04-29T10:13:38+00:00https://thepharmanavigator.com/news/amgens-maritide-challenges-weight-loss-drug-market-with-innovative-approach-and-promising-early-results/2024-04-08T12:59:00+00:00https://thepharmanavigator.com/news/amgens-maritide-demonstrates-weight-loss-potential/2024-02-21T10:54:00+00:00https://thepharmanavigator.com/news/amgens-maritide-to-face-phase-3-trials-targeting-liver-kidney-diseases/2024-09-16T09:23:00+00:00https://thepharmanavigator.com/news/amgens-uplizna-gains-fda-nod-for-rare-inflammatory-disease-indication/2025-04-16T08:30:00+00:00https://thepharmanavigator.com/news/amm-and-srt-team-up-to-drive-the-rna-medicine-agenda/2026-06-22T13:00:31+00:00https://thepharmanavigator.com/news/amplifybio-shuts-down-operations/2025-04-14T08:12:00+00:00https://thepharmanavigator.com/news/amylyx-withdraws-als-drug-relyvrio-following-trial-failure-cuts-70-of-staff/2024-04-22T09:04:00+00:00https://thepharmanavigator.com/news/analyzing-the-1st-half-drug-sales-from-top-pharma-companies/2024-08-11T12:33:00+00:00https://thepharmanavigator.com/news/apellis-gains-fda-nod-for-c3g-and-primary-ic-mpgn-treatment/2025-07-30T09:07:46+00:00https://thepharmanavigator.com/news/approaching-a-significant-transformation/2025-09-01T11:48:00+00:00https://thepharmanavigator.com/news/aptamer-group-and-astrazeneca-announce-sirna-delivery-collaboration/2024-07-17T09:17:00+00:00https://thepharmanavigator.com/news/aptar-pharma-expands-manufacturing-capacity-in-north-america/2024-10-12T09:17:00+00:00https://thepharmanavigator.com/news/aptar-pharma-to-showcase-innovations-and-sustainability-focus-at-cphi-barcelona/2023-10-11T08:11:00+00:00https://thepharmanavigator.com/news/aptar-recognized-among-forbes-top-50-companies-for-women-in-2024/2024-11-19T09:12:35+00:00https://thepharmanavigator.com/news/aragen-secures-100-million-to-expand-cdmo-services/2025-01-31T10:48:00+00:00https://thepharmanavigator.com/news/architecting-a-new-framework-for-supply-resilience/2026-04-09T08:20:08+00:00https://thepharmanavigator.com/news/argo-expands-collaboration-with-novartis-with-sirna-deal/2025-09-11T10:36:35+00:00https://thepharmanavigator.com/news/asahi-kaseis-bionova-expands-into-plasmid-dna/2024-06-11T04:00:00+00:00https://thepharmanavigator.com/news/ascend-advanced-therapies-partners-with-ew-healthcare/2024-11-29T10:35:00+00:00https://thepharmanavigator.com/news/ascidian-partners-with-eli-lilly-on-rna-editing-for-monogenic-kidney-targets/2026-06-03T15:52:45+00:00https://thepharmanavigator.com/news/asimov-and-lotte-biologics-collaborate-to-accelerate-gmp-manufacturing/2025-03-24T14:47:00+00:00https://thepharmanavigator.com/news/aspire-pharma-acquires-cenote-pharma/2024-03-25T15:33:00+00:00https://thepharmanavigator.com/news/astrazeneca-commits-usd-35-billion-to-us-biopharmaceutical-expansion/2024-11-30T10:41:00+00:00https://thepharmanavigator.com/news/astrazeneca-completes-acquisition-of-fusion-pharmaceuticals/2024-06-19T08:21:00+00:00https://thepharmanavigator.com/news/astrazeneca-gains-european-approval-for-perioperative-immunotherapy-for-mibc/2025-07-07T11:06:58+00:00https://thepharmanavigator.com/news/astrazeneca-gains-nod-from-fda-for-perioperative-imfinzi-based-regimen/2025-12-01T16:12:47+00:00https://thepharmanavigator.com/news/astrazeneca-joins-pfizer-in-us-drug-pricing-program/2025-10-14T09:37:19+00:00https://thepharmanavigator.com/news/astrazeneca-purchases-novel-small-molecule-lipoprotein-a-disruptor/2024-10-19T14:35:00+00:00https://thepharmanavigator.com/news/astrazeneca-targets-80-billion-revenue-by-2030/2024-06-03T12:59:00+00:00https://thepharmanavigator.com/news/atmps-at-the-precipice-of-success-or-failure/2026-03-26T11:41:26+00:00https://thepharmanavigator.com/news/avenacy-to-present-year-one-milestones-at-cphi-milan-2024/2024-10-10T11:10:00+00:00https://thepharmanavigator.com/news/axplora-enhances-adc-manufacturing-at-le-mans-facility/2025-03-22T12:01:00+00:00https://thepharmanavigator.com/news/axplora-invests-to-advance-life-changing-therapies-in-france/2025-02-20T07:30:00+00:00https://thepharmanavigator.com/news/az-expands-oncology-reach-with-fusion-acquisition/2024-04-05T08:47:00+00:00https://thepharmanavigator.com/news/balancing-innovation-and-cost-through-the-right-partnership/2025-12-22T13:00:00+00:00https://thepharmanavigator.com/news/balancing-innovation-with-integrity-in-pharma-packaging/2025-09-03T14:11:00+00:00https://thepharmanavigator.com/news/bayer-launches-healthy-aging-ecosystem-for-consumers/2024-09-17T09:26:00+00:00https://thepharmanavigator.com/news/bayer-strengthens-ophthalmology-pipeline-with-perfuse-therapeutics-acquisition/2026-05-07T15:53:44+00:00https://thepharmanavigator.com/news/beigenes-new-us-hub-eyes-biologics-deals-and-expansion/2024-08-09T09:01:00+00:00https://thepharmanavigator.com/news/bend-adds-particle-engineering-and-spray-drying-capabilities-with-new-suites/2025-06-23T09:28:56+00:00https://thepharmanavigator.com/news/bend-and-starton-collaborate-on-oral-sustained-release-form-of-star-lld/2025-07-01T15:14:41+00:00https://thepharmanavigator.com/news/bend-bioscience-expands-commercial-spray-drying-and-granulation-capabilities/2025-04-02T09:26:24+00:00https://thepharmanavigator.com/news/berry-to-showcase-innovative-drug-delivery-solutions/2024-09-21T12:19:00+00:00https://thepharmanavigator.com/news/beyond-the-settlement/2025-11-19T12:42:00+00:00https://thepharmanavigator.com/news/bicara-therapeutics-closes-362-mn-ipo-amid-busy-biotech-listings/2024-09-27T09:46:00+00:00https://thepharmanavigator.com/news/big-pharma-layoffs-surge-in-2024-amid-industry-challenges/2025-01-16T09:47:00+00:00https://thepharmanavigator.com/news/bio-2024-adapting-payment-models-for-gene-therapy/2024-06-26T08:44:00+00:00https://thepharmanavigator.com/news/bio-2025-broadening-potential-use-of-long-acting-injectables/2025-06-10T15:56:13+00:00https://thepharmanavigator.com/news/bio-2025-fit-for-purpose-manufacturing-for-personalized-therapy/2025-06-11T12:09:00+00:00https://thepharmanavigator.com/news/bio-2025-getting-to-the-root-of-cardiopulmonary-diseases-with-epigenetic-modulation/2025-06-12T14:45:00+00:00https://thepharmanavigator.com/news/bio-2025-investment-limiting-effect-of-the-capability-gap/2025-06-17T15:29:48+00:00https://thepharmanavigator.com/news/bio-2025-making-biologics-manufacturing-accessible/2025-06-12T10:26:46+00:00https://thepharmanavigator.com/news/bio-2025-providing-longer-lasting-potency-effects/2025-06-11T14:17:33+00:00https://thepharmanavigator.com/news/bio-2025-tackling-metastatic-tumors-with-radiotherapeutics/2025-06-11T16:53:18+00:00https://thepharmanavigator.com/news/bio-2025-targeting-the-microenvironment-to-treat-solid-tumors/2025-06-12T08:14:29+00:00https://thepharmanavigator.com/news/bio-2025-uncovering-the-next-innovations-in-gene-editing/2025-06-09T08:00:00+00:00https://thepharmanavigator.com/news/bio-2025-understanding-the-nuances-of-cell-therapy-projects/2025-07-09T09:05:46+00:00https://thepharmanavigator.com/news/bio-2025-unlocking-cellular-secrets-with-multi-omics/2025-06-10T13:58:49+00:00https://thepharmanavigator.com/news/bio-2026-beyond-the-dna-blueprint/2026-06-23T13:22:54+00:00https://thepharmanavigator.com/news/bio-2026-bridging-the-complexity-gap/2026-06-24T15:45:40+00:00https://thepharmanavigator.com/news/bio-2026-building-supply-ahead-of-demand/2026-06-18T09:37:32+00:00https://thepharmanavigator.com/news/bio-2026-engineering-long-acting-precision/2026-06-18T08:52:41+00:00https://thepharmanavigator.com/news/bio-2026-overcoming-the-complexity-challenge/2026-06-18T08:05:02+00:00https://thepharmanavigator.com/news/bio-2026-strategizing-for-specialized-services/2026-06-18T10:19:41+00:00https://thepharmanavigator.com/news/bio-announces-major-restructuring-and-staff-reduction/2024-06-01T11:44:00+00:00https://thepharmanavigator.com/news/biocentriq-appoint-new-ceo/2024-09-25T09:25:00+00:00https://thepharmanavigator.com/news/bioduro-atombeat-join-forces-to-speed-up-peptide-drug-discovery/2025-08-08T09:57:39+00:00https://thepharmanavigator.com/news/bioduro-expands-peptide-synthesis-with-new-shanghai-facility/2025-01-26T09:26:00+00:00https://thepharmanavigator.com/news/bioduro-opens-new-laboratory-in-shanghai/2025-04-02T09:19:48+00:00https://thepharmanavigator.com/news/bioduro-secures-two-ecovadis-gold-medals-for-sustainability-excellence/2025-01-09T08:16:00+00:00https://thepharmanavigator.com/news/bioduro-sundia-appoints-alan-findlater-as-new-chief-commercial-officer/2024-12-14T10:19:00+00:00https://thepharmanavigator.com/news/bioduro-sundia-appoints-new-ceo-to-drive-global-expansion/2024-10-03T10:24:26+00:00https://thepharmanavigator.com/news/bioduro-sundia-opens-new-kilo-lab-in-shanghais-ftz/2024-10-24T11:17:45+00:00https://thepharmanavigator.com/news/bioduro-sundia-strengthens-discovery-services/2024-10-06T10:55:00+00:00https://thepharmanavigator.com/news/bioduro-taps-industry-veteran-yaohui-ji-to-drive-crdmo-expansion/2025-11-13T16:09:53+00:00https://thepharmanavigator.com/news/bionova-appoints-bionique-as-preferred-provider-for-mycoplasma-testing/2025-04-02T09:23:26+00:00https://thepharmanavigator.com/news/bionova-expands-with-new-fremont-process-development-facility/2025-03-04T09:40:00+00:00https://thepharmanavigator.com/news/bionova-to-open-pdna-development-and-production-facility-in-texas/2025-08-13T15:24:54+00:00https://thepharmanavigator.com/news/biontech-faces-nih-default-notice-over-covid-19-vaccine-royalties/2024-04-11T09:10:00+00:00https://thepharmanavigator.com/news/biontech-to-acquire-biotheus-to-strengthen-oncology-pipeline/2024-12-02T10:56:00+00:00https://thepharmanavigator.com/news/biopharma-demand-continues-to-fuel-cdmo-services-growth/2024-05-28T12:46:00+00:00https://thepharmanavigator.com/news/biopharma-mampa-in-the-year-of-execution-certainty/2026-01-29T11:12:42+00:00https://thepharmanavigator.com/news/biosecure-act-excluded-from-us-defense-bill-boosting-chinese-biotech-firms/2024-12-19T09:02:00+00:00https://thepharmanavigator.com/news/biosecure-act-threatens-us-biotech-ties-with-chinese-cros-and-cdmos/2024-09-28T09:51:00+00:00https://thepharmanavigator.com/news/biotech-financing-the-dynamics-of-strategic-investment/2024-09-06T08:22:00+00:00https://thepharmanavigator.com/news/biotech-startups-merge-into-alys-pharmaceuticals/2024-02-23T10:56:00+00:00https://thepharmanavigator.com/news/biotech-stocks-surge-amid-public-health-concerns-over-avian-flu/2024-06-08T08:11:00+00:00https://thepharmanavigator.com/news/bloom-biorenewables-and-valsynthse-scale-up-sustainable-lignin-production-for-polyurethane/2024-04-28T09:10:00+00:00https://thepharmanavigator.com/news/bms-pay-674m-for-generative-ai-drug-discovery/2024-02-28T12:37:00+00:00https://thepharmanavigator.com/news/bms-to-acquire-orbital-and-strengthen-cell-therapy-portfolio/2025-10-10T15:51:49+00:00https://thepharmanavigator.com/news/boehringer-strikes-up-deal-with-re-vana-to-deliver-ophthalmic-pipeline/2025-07-29T14:20:37+00:00https://thepharmanavigator.com/news/bora-adds-small-scale-isolator-line-to-baltimore-facility/2025-05-30T13:20:05+00:00https://thepharmanavigator.com/news/bora-aims-to-expand-us-operations-with-emergent-sterile-manufacturing-facility/2024-06-30T14:33:00+00:00https://thepharmanavigator.com/news/bora-biologics-expands-through-acquisition-and-partnership/2024-09-25T10:59:00+00:00https://thepharmanavigator.com/news/bora-completes-emergent-fill-finish-facility-deal/2024-08-26T13:05:00+00:00https://thepharmanavigator.com/news/bora-makes-strategic-investment-in-tanvex-to-combine-biomanufacturing/2024-08-29T13:27:00+00:00https://thepharmanavigator.com/news/bormioli-to-showcase-sustainable-packaging-at-cphi-milan-2024/2024-10-07T11:01:00+00:00https://thepharmanavigator.com/news/boryung-corp-and-lotus-pharmaceutical-forge-cdmo-partnership/2024-12-20T09:47:00+00:00https://thepharmanavigator.com/news/brenntag-budenheim-cooperate-to-offer-phosphate-based-excipients-in-parts-of-europe/2025-07-16T10:53:04+00:00https://thepharmanavigator.com/news/bridging-the-bench-to-commercial-gap/2025-08-26T10:31:00+00:00https://thepharmanavigator.com/news/bridging-the-solubility-barrier-with-bile-acids/2026-07-21T09:00:01+00:00https://thepharmanavigator.com/news/bristol-myers-squibb-announces-layoffs-at-mirati-following-58-billion-acquisition/2024-04-13T08:38:00+00:00https://thepharmanavigator.com/news/bristol-myers-squibb-implements-layoffs-in-new-jersey/2024-12-10T15:57:00+00:00https://thepharmanavigator.com/news/bristol-myers-squibbs-sign-380-mn-deal-with-cellares-to-expand-cell-therapy-access/2024-05-03T12:00:00+00:00https://thepharmanavigator.com/news/building-a-modern-biotech-workforce/2026-06-04T10:18:14+00:00https://thepharmanavigator.com/news/building-a-world-class-cdmo-for-reliable-global-supply/2025-02-04T15:31:52+00:00https://thepharmanavigator.com/news/can-cdmos-redefine-sustainability-in-pharmaceutical-manufacturing/2025-03-03T09:33:00+00:00https://thepharmanavigator.com/news/capitalizing-on-a-boom-in-injectable-therapies/2024-06-29T09:30:00+00:00https://thepharmanavigator.com/news/catalent-and-galapagos-collaborate-to-enhance-decentralized-car-t-manufacturing/2025-02-14T10:58:00+00:00https://thepharmanavigator.com/news/catalent-appoints-three-industry-leaders-to-board/2025-03-17T12:07:00+00:00https://thepharmanavigator.com/news/catalent-expands-asd-capabilities-in-boston/2024-10-27T12:26:00+00:00https://thepharmanavigator.com/news/cdmos-on-the-rise-powering-the-future-of-biopharma-and-pharma/2024-08-24T13:00:00+00:00https://thepharmanavigator.com/news/celltrion-expands-global-cdmo-operations-with-indian-research-hub/2025-01-12T08:52:00+00:00https://thepharmanavigator.com/news/celltrion-secures-73-million-cdmo-deal/2024-11-16T14:38:00+00:00https://thepharmanavigator.com/news/celltrion-to-break-ground-on-cdmo-plant-in-2025/2024-12-12T09:41:00+00:00https://thepharmanavigator.com/news/celltrion-to-establish-wholly-owned-cdmo-subsidiary-by-end-of-2024/2024-10-31T13:51:00+00:00https://thepharmanavigator.com/news/celltrion-ventures-into-cdmo-market-and-eyes-expansion/2024-09-25T09:32:00+00:00https://thepharmanavigator.com/news/cellular-origins-completes-series-a-financing-round/2025-12-11T09:34:00+00:00https://thepharmanavigator.com/news/charles-river-laboratories-signs-deals-to-sell-cdmo-and-discovery-assets/2026-03-06T10:26:03+00:00https://thepharmanavigator.com/news/chikungunya-vaccine-under-safety-review-by-ema/2025-05-10T14:23:00+00:00https://thepharmanavigator.com/news/chime-biologics-targets-expansion-in-asia-europe-while-navigating-biosecure-act/2024-08-21T12:51:00+00:00https://thepharmanavigator.com/news/circio-and-acuitas-initiate-technology-evaluation-agreement/2026-04-27T15:08:13+00:00https://thepharmanavigator.com/news/circio-demonstrates-increased-aav-potentcy-with-circular-rna-technology/2025-09-10T12:38:00+00:00https://thepharmanavigator.com/news/circio-expands-circvec-platform-with-genassist-collaboration/2026-06-05T11:07:58+00:00https://thepharmanavigator.com/news/circio-expands-into-novel-lab-facilities-in-stockholm/2025-07-08T09:24:07+00:00https://thepharmanavigator.com/news/circio-partners-with-avenue-biosciences-to-boost-secreted-proteins-in-aav-therapies/2026-08-01T15:27:35+00:00https://thepharmanavigator.com/news/circio-unveils-next-generation-circular-rna-expression-platform/2025-11-27T15:40:50+00:00https://thepharmanavigator.com/news/closing-the-bioprocessing-gap/2026-08-06T14:12:46+00:00https://thepharmanavigator.com/news/codis-announces-three-senior-appointments-to-fuel-us-and-european-expansion/2026-06-30T09:09:21+00:00https://thepharmanavigator.com/news/codis-expands-european-footprint-with-catalent-nottingham-facility-acquisition/2026-08-05T15:08:02+00:00https://thepharmanavigator.com/news/codis-expands-spray-drying-capability-through-catalent-facility-acquisition/2026-07-13T11:12:33+00:00https://thepharmanavigator.com/news/codis-significantly-invests-in-uk-spray-drying-capacity-for-asds/2026-03-10T10:17:15+00:00https://thepharmanavigator.com/news/cohance-appoints-yann-dherve-as-new-ceo/2025-08-07T15:51:02+00:00https://thepharmanavigator.com/news/cohance-lifesciences-invests-heavily-in-capabilities-in-india-and-us/2025-08-18T16:29:21+00:00https://thepharmanavigator.com/news/colorcon-discuss-expedited-product-development-and-tio2-free-coatings/2023-10-09T09:00:00+00:00https://thepharmanavigator.com/news/committing-to-a-sustainable-future-in-biomanufacturing/2025-09-03T09:53:00+00:00https://thepharmanavigator.com/news/company-launches-to-accelerate-development-of-a-novel-cgt-for-pediatric-cp/2026-02-20T10:11:22+00:00https://thepharmanavigator.com/news/consortium-forms-to-develop-fully-automated-robotics-cgt-manufacturing-platform/2025-07-11T16:49:38+00:00https://thepharmanavigator.com/news/cordenpharma-and-viking-forge-partnership-for-glp-1-drug-candidate-vk2735/2025-03-25T14:51:00+00:00https://thepharmanavigator.com/news/corerx-societal-cdmo-and-bend-bioscience-merge-under-bioscience-brand/2024-09-07T08:32:00+00:00https://thepharmanavigator.com/news/cphi-americas-2025-a-growing-service-offering/2025-05-14T10:30:00+00:00https://thepharmanavigator.com/news/cphi-americas-2025-driving-innovation-with-bioduro/2025-05-15T09:02:00+00:00https://thepharmanavigator.com/news/cphi-americas-2025-meeting-biomanufacturing-demand/2025-05-14T13:12:00+00:00https://thepharmanavigator.com/news/cphi-americas-2025-navigating-complexities-with-strategic-partnerships/2025-05-14T08:00:00+00:00https://thepharmanavigator.com/news/cphi-americas-2025-working-end-to-end/2025-05-14T15:56:00+00:00https://thepharmanavigator.com/news/cphi-americas-2026-a-platform-for-strategic-conversation/2026-05-28T10:08:40+00:00https://thepharmanavigator.com/news/cphi-americas-2026-anchoring-the-pipeline/2026-05-28T06:57:38+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-a-global-stage-to-connect-and-learn/2025-10-22T14:45:15+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-achieving-a-longer-release-for-injectables/2025-10-22T10:24:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-achieving-the-three-pillars-of-flexibility-reliability-and-sustainability/2025-10-23T15:48:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-advancing-innovation-from-concept-to-commercialization/2025-10-29T20:15:14+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-avoiding-manufacturing-failures-with-integrated-planning/2025-10-23T13:02:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-gaining-an-advantage-with-rtu-cartridges/2025-10-30T08:42:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-getting-the-balance-between-cost-and-productivity-right-with-innovation/2025-10-24T14:34:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-managing-complexity-and-moisture-sensitivity/2025-10-23T10:36:41+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-new-trends-deliver-promise-in-osds-from-core-to-coating-to-functional-packaging/2025-10-24T09:35:30+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-scaling-3d-printing-and-taking-a-global-approach-to-supply-chain-security/2025-10-21T09:39:15+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-the-benefits-of-an-aligned-and-integrated-approach/2025-10-22T12:33:52+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-the-central-role-of-india-in-building-a-resilient-supply-chain/2025-10-20T18:46:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-the-latest-trends-fueling-demand-for-manufacturing/2025-10-23T18:13:00+00:00https://thepharmanavigator.com/news/cphi-frankfurt-2025-unlocking-the-potential-of-3d-cell-cultures-in-vaccine-production-with-novel-nanofiber-platform/2025-10-27T18:14:00+00:00https://thepharmanavigator.com/news/cphi-milan-survey-predicts-cdmo-growth-and-mixed-reactions-to-biosecure-act/2024-10-02T10:05:00+00:00https://thepharmanavigator.com/news/cptx-and-nanocell-win-european-funding-for-quiet-car-project/2025-08-19T09:14:45+00:00https://thepharmanavigator.com/news/cracking-the-oral-peptide-code/2026-08-26T15:59:12+00:00https://thepharmanavigator.com/news/cro-cmo-cdmo-whats-next/2024-12-04T15:14:31+00:00https://thepharmanavigator.com/news/csl-gains-fda-approval-for-its-preventative-hae-treatment/2025-06-25T13:17:55+00:00https://thepharmanavigator.com/news/curia-enhances-sterile-manufacturing-integrity-with-upgraded-aseptic-suites/2026-05-25T10:25:31+00:00https://thepharmanavigator.com/news/curium-acquires-monrol-for-strategic-expansion-in-nuclear-medicine/2025-04-02T09:37:01+00:00https://thepharmanavigator.com/news/curve-therapeutics-secures-over-50-million-to-accelerate-its-discovery-platform/2024-03-15T10:36:00+00:00https://thepharmanavigator.com/news/cyllene-therapeutics-successfully-raises-millions-to-advance-genetic-medicine-candidate/2026-07-07T15:56:08+00:00https://thepharmanavigator.com/news/dark-horse-consulting-acquires-biotechlogic-launches-icmc-certification-program/2024-10-15T13:55:00+00:00https://thepharmanavigator.com/news/dcat-week-2026-a-future-beyond-the-static-supply-chain/2026-04-14T12:36:59+00:00https://thepharmanavigator.com/news/dcat-week-2026-aligning-science-and-strategy/2026-03-25T19:28:04+00:00https://thepharmanavigator.com/news/dcat-week-2026-building-a-sustainable-supply/2026-03-18T16:34:54+00:00https://thepharmanavigator.com/news/dcat-week-2026-proactive-planning-for-osd-forms/2026-04-06T19:02:15+00:00https://thepharmanavigator.com/news/dcat-week-2026-solving-the-complexity-crisis/2026-03-24T08:33:03+00:00https://thepharmanavigator.com/news/dcat-week-2026-the-domestic-imperative-for-manufacturing/2026-03-18T10:33:21+00:00https://thepharmanavigator.com/news/de-risking-the-scale-up-pathway/2026-06-08T18:27:37+00:00https://thepharmanavigator.com/news/delivering-success-the-importance-of-considering-drug-delivery-early/2025-12-18T10:39:42+00:00https://thepharmanavigator.com/news/delpharm-secures-usd-42-mn-investment-to-upgrade-injectables-plant/2025-04-02T09:39:46+00:00https://thepharmanavigator.com/news/delpharm-set-to-transform-boucherville-facility-after-securing-government-funding/2025-09-04T18:54:00+00:00https://thepharmanavigator.com/news/dicot-pharma-unveils-moa-findings-for-potency-therapy/2025-06-03T10:41:56+00:00https://thepharmanavigator.com/news/disrupting-the-bioprocessing-footprint/2026-06-25T12:05:46+00:00https://thepharmanavigator.com/news/dizal-gains-fda-nod-for-oral-therapy-to-treat-nsclc-with-egfr-exon-20-insertion-mutations/2025-07-03T17:39:44+00:00https://thepharmanavigator.com/news/do-biosimilars-represent-a-threat-to-big-pharma/2024-04-30T13:02:00+00:00https://thepharmanavigator.com/news/do-glp-1-drugs-pose-a-threat-to-national-healthcare-systems/2024-07-29T12:20:00+00:00https://thepharmanavigator.com/news/dotbio-and-bora-biologics-join-forces-to-advance-db007/2025-01-28T09:57:00+00:00https://thepharmanavigator.com/news/driving-progress-in-biomanufacturing/2025-10-07T17:19:00+00:00https://thepharmanavigator.com/news/drug-development-costs-set-to-increase-amid-biosecure-act/2024-08-02T13:32:00+00:00https://thepharmanavigator.com/news/drug-pricing-in-the-us-a-careful-balance-between-the-white-house-patients-big-pharma/2024-04-03T09:13:00+00:00https://thepharmanavigator.com/news/drugs-losing-exclusivity-in-2024/2024-03-23T11:51:00+00:00https://thepharmanavigator.com/news/dyadic-secures-gates-foundation-grant-to-develop-affordable-antibodies/2024-12-11T09:35:00+00:00https://thepharmanavigator.com/news/ecolab-opens-new-bioprocessing-lab-in-eastern-us/2025-05-20T08:44:17+00:00https://thepharmanavigator.com/news/egenesis-secures-191-million-for-pig-kidney-transplants/2024-09-19T09:56:00+00:00https://thepharmanavigator.com/news/eikon-therapeutics-secures-usd-350-million-in-series-d-funding-to-advance-clinical-programs/2025-03-13T11:48:00+00:00https://thepharmanavigator.com/news/eleva-and-3pbiovian-forge-partnership-to-increase-production-capacity/2025-02-18T11:08:00+00:00https://thepharmanavigator.com/news/eli-lilly-embraces-oblique-antibody-discovery-for-new-high-value-targets/2024-09-04T13:53:00+00:00https://thepharmanavigator.com/news/eli-lilly-expands-ai-horizons-with-genetic-leap-partnership/2024-09-11T09:11:00+00:00https://thepharmanavigator.com/news/eli-lilly-expands-us-manufacturing-with-new-pennsylvania-facility/2026-02-09T11:26:36+00:00https://thepharmanavigator.com/news/eli-lilly-partners-with-amazon-pharmacy-to-deliver-medication-via-lillydirect/2024-03-29T10:33:00+00:00https://thepharmanavigator.com/news/eli-lilly-sees-glp-1-success-highlights-ongoing-challenges/2024-08-20T12:45:00+00:00https://thepharmanavigator.com/news/eli-lilly-sues-over-unauthorized-selling-of-counterfeit-mounjaro-and-zepbound-drugs/2024-05-27T10:15:00+00:00https://thepharmanavigator.com/news/eli-lilly-to-invest-in-us-manufacturing-expansion/2025-03-15T11:58:00+00:00https://thepharmanavigator.com/news/empowering-customer-process-excellence/2026-07-24T08:49:48+00:00https://thepharmanavigator.com/news/encell-partners-with-cell-resources-and-secures-cdmo-contract-with-cellebrain/2025-03-28T16:35:00+00:00https://thepharmanavigator.com/news/endpoints-news-manufacturing-day-2024/2024-07-26T14:37:00+00:00https://thepharmanavigator.com/news/enzene-announces-official-inauguration-of-new-us-biomanufacturing-facility/2025-09-09T15:30:47+00:00https://thepharmanavigator.com/news/enzene-expands-new-jersey-facility-to-boost-next-gen-biomanufacturing/2025-06-24T14:13:21+00:00https://thepharmanavigator.com/news/enzene-initiates-commercial-supply-of-pertuzumab/2025-09-25T12:44:00+00:00https://thepharmanavigator.com/news/enzene-launches-nex-to-support-local-continuous-biomanufacturing/2026-08-11T13:31:01+00:00https://thepharmanavigator.com/news/enzene-secures-eu-gmp-certification-to-expand-global-biologics-capabilities/2025-03-05T10:17:00+00:00https://thepharmanavigator.com/news/epicrispr-secures-financing-to-advance-its-first-in-class-epigenetic-fshd-therapy/2026-08-15T11:56:18+00:00https://thepharmanavigator.com/news/esteve-cdmo-expands-spray-drying-capacity-in-girona/2026-03-29T11:38:21+00:00https://thepharmanavigator.com/news/esteve-expands-us-cdmo-capabilities-through-acquisition-of-regis-technologies/2025-08-01T09:41:14+00:00https://thepharmanavigator.com/news/esteve-invests-millions-into-chicago-facility-expansion/2026-03-06T17:28:17+00:00https://thepharmanavigator.com/news/esteve-qumica-to-expand-us-manufacturing-capabilities/2025-04-02T09:30:56+00:00https://thepharmanavigator.com/news/ethyreal-bio-launches-to-advance-dual-targeting-thyroid-therapy/2026-06-10T21:34:44+00:00https://thepharmanavigator.com/news/eu-regulators-scrutinize-novo-holdings-catalent-acquisition/2024-11-19T09:16:44+00:00https://thepharmanavigator.com/news/eurofins-cdmo-alphora-expands-api-capacity-with-new-facility/2024-07-25T08:54:00+00:00https://thepharmanavigator.com/news/eurofins-cdmo-alphora-inc-to-build-advanced-gmp-biologics-manufacturing-facility/2024-11-26T10:27:00+00:00https://thepharmanavigator.com/news/european-commission-approves-first-crispr-gene-edited-therapy-for-blood-disorder/2024-02-26T14:02:00+00:00https://thepharmanavigator.com/news/everest-medicines-launches-iit-for-personalized-mrna-cancer-vaccine/2024-09-05T14:37:00+00:00https://thepharmanavigator.com/news/evonik-announces-260-more-layoffs-as-part-of-multi-year-restructuring/2024-10-29T13:37:00+00:00https://thepharmanavigator.com/news/evonik-ethris-collaborate-to-advance-next-gen-nucleic-acid-delivery-offerings/2025-09-15T09:25:29+00:00https://thepharmanavigator.com/news/eyepoint-positions-duravyu-as-a-potential-treatment-for-wet-amd/2026-08-21T15:32:20+00:00https://thepharmanavigator.com/news/fda-accepts-gsks-gepotidacin-for-priority-review/2025-08-11T17:00:00+00:00https://thepharmanavigator.com/news/fda-approves-abbvies-jak-inhibitor-therapy-to-treat-gca/2025-04-30T09:12:27+00:00https://thepharmanavigator.com/news/fda-approves-first-bcma-targeted-relapsed-or-refractory-multiple-myeloma-therapy/2024-04-24T09:10:00+00:00https://thepharmanavigator.com/news/fda-approves-first-nasal-spray-for-allergic-reactions/2024-08-13T13:20:00+00:00https://thepharmanavigator.com/news/fda-approves-lumicells-innovative-imaging-system-for-enhancing-breast-cancer-surgery/2024-05-02T14:01:00+00:00https://thepharmanavigator.com/news/fda-approves-new-pah-treatments-opsynvi-and-winrevair/2024-04-15T08:51:00+00:00https://thepharmanavigator.com/news/fda-approves-zevtera-for-multiple-bacterial-infections/2024-04-21T10:49:00+00:00https://thepharmanavigator.com/news/fda-clears-immpact-bios-car-t-ms-therapy/2024-09-03T13:51:00+00:00https://thepharmanavigator.com/news/fda-considers-broader-use-of-gsks-rsv-vaccine-for-at-risk-adults/2025-07-21T13:04:22+00:00https://thepharmanavigator.com/news/fda-cracks-down-on-illegal-weight-loss-drugs/2024-02-29T14:25:00+00:00https://thepharmanavigator.com/news/fda-expands-label-for-sareptas-duchenne-gene-therapy/2024-07-02T10:38:00+00:00https://thepharmanavigator.com/news/fda-extends-review-of-astrazenecas-camizestran/2026-06-02T08:01:32+00:00https://thepharmanavigator.com/news/fda-grants-priority-review-of-sbla-for-datopotamab-deruxtecan/2026-02-04T08:05:47+00:00https://thepharmanavigator.com/news/fda-halts-neumoras-schizophrenia-drug-trials-over-preclinical-safety-concerns/2024-04-28T13:05:00+00:00https://thepharmanavigator.com/news/fda-inspection-backlog-delays-overseas-drug-approvals/2024-09-25T09:04:00+00:00https://thepharmanavigator.com/news/fda-issues-complete-response-letter-for-abbvies-parkinsons-treatment/2024-07-11T10:38:00+00:00https://thepharmanavigator.com/news/fda-issues-warning-letters-for-data-integrity-breaches-in-global-pharma-manufacturing/2024-03-28T14:18:00+00:00https://thepharmanavigator.com/news/fda-rejects-regenerons-blood-cancer-therapy-odronextamab-pending-more-data/2024-04-14T10:35:00+00:00https://thepharmanavigator.com/news/fda-releases-guidance-for-platform-technology/2024-06-10T11:24:00+00:00https://thepharmanavigator.com/news/fda-removes-wegovy-from-shortage-list-as-novo-nordisk-resolves-supply-issues/2024-11-17T14:44:00+00:00https://thepharmanavigator.com/news/fda-schedules-june-deadline-for-potential-approval-and-broader-usage-of-sareptas-duchenne-genetic-treatment/2024-03-05T10:27:00+00:00https://thepharmanavigator.com/news/fda-seeks-public-input-on-biosimilar-development-guidance/2024-08-08T08:51:00+00:00https://thepharmanavigator.com/news/fda-starts-implementing-ai-rollout-across-all-centers-nbsp/2025-05-09T11:38:30+00:00https://thepharmanavigator.com/news/fda-to-waive-drug-registration-fees-for-smaller-companies/2024-03-12T10:22:08+00:00https://thepharmanavigator.com/news/figuring-out-the-new-economics-of-niche/2026-04-23T08:55:40+00:00https://thepharmanavigator.com/news/finalists-for-cphi-pharma-awards-2025-announced/2025-09-22T15:09:00+00:00https://thepharmanavigator.com/news/firefly-bio-launches-with-94-million-for-innovative-cancer-therapy-platform/2024-03-01T09:35:00+00:00https://thepharmanavigator.com/news/fireside-chat-with-stephen-j-ubl-president-and-ceo-phrma/2024-01-07T10:13:00+00:00https://thepharmanavigator.com/news/first-targeted-csu-therapy-for-children-gets-nod-from-european-commission/2026-04-17T09:48:05+00:00https://thepharmanavigator.com/news/five-trends-that-will-redefine-the-cdmo-industry-in-2025/2025-01-06T07:04:00+00:00https://thepharmanavigator.com/news/formation-bio-secures-372-million-for-ai-driven-drug-development/2024-07-10T04:43:00+00:00https://thepharmanavigator.com/news/from-complex-apis-to-patient-centricity-the-power-of-oral-dosage-innovation/2025-07-09T18:15:00+00:00https://thepharmanavigator.com/news/frontier-scientific-to-construct-north-americas-largest-temperature-controlled-facility/2025-02-25T09:05:00+00:00https://thepharmanavigator.com/news/ftc-supports-rule-change-to-expose-anticompetitive-drug-patent-deals/2024-06-24T14:15:00+00:00https://thepharmanavigator.com/news/fujifilm-diosynth-opens-new-microbial-manufacturing-facility-in-the-uk/2024-08-25T13:02:00+00:00https://thepharmanavigator.com/news/fujifilm-diosynths-usd-8-billion-expansion-set-to-peak-in-2025/2025-02-06T09:20:00+00:00https://thepharmanavigator.com/news/funding-to-battle-genetic-disorders-and-cancer/2024-02-16T14:21:00+00:00https://thepharmanavigator.com/news/further-opposition-voiced-on-novo-holdings-catalent-acquisition/2024-10-24T11:13:25+00:00https://thepharmanavigator.com/news/future-proofing-the-small-molecule-pipeline-with-spray-drying/2026-05-07T09:30:24+00:00https://thepharmanavigator.com/news/gbi-appoints-industry-veteran-sven-lee-to-board-of-directors/2025-03-23T14:42:00+00:00https://thepharmanavigator.com/news/gelita-to-showcase-new-softgel-and-collagen-solutions/2024-09-24T08:41:00+00:00https://thepharmanavigator.com/news/gempharmatech-advances-expansion-strategy-with-new-facility-in-san-diego/2025-04-22T13:47:49+00:00https://thepharmanavigator.com/news/gene-therapy-improves-hearing-in-children-with-profound-genetic-hearing-loss/2025-10-13T17:51:00+00:00https://thepharmanavigator.com/news/genmab-acquires-profoundbio-expands-into-adc-cancer-treatments/2024-04-20T08:51:00+00:00https://thepharmanavigator.com/news/genmab-ceo-urges-western-pharma-to-leverage-chinese-biotech-innovation/2024-05-28T08:51:00+00:00https://thepharmanavigator.com/news/getting-your-molecule-thru-the-clinic-in-these-challenging-times/2024-01-25T09:41:00+00:00https://thepharmanavigator.com/news/ginkgo-bioworks-expands-layoffs-to-400-job-cuts/2024-07-12T07:45:00+00:00https://thepharmanavigator.com/news/global-cmo-and-cdmo-market-valuation-predicted-to-reach-40-billion-by-2033/2024-07-13T07:00:00+00:00https://thepharmanavigator.com/news/global-sterile-injectable-cdmo-market-to-hit-337-billion-by-2034/2024-06-25T14:20:00+00:00https://thepharmanavigator.com/news/glp-1-discovery-award-recognition/2024-09-24T08:58:00+00:00https://thepharmanavigator.com/news/granite-bio-emerges-from-stealth-to-advance-immunology-pipeline/2025-04-28T10:52:45+00:00https://thepharmanavigator.com/news/granules-india-acquires-senn-chemicals-to-expand-into-peptide-therapeutics/2025-04-16T08:43:00+00:00https://thepharmanavigator.com/news/granules-india-buys-its-way-into-peptide-market/2025-03-08T11:22:00+00:00https://thepharmanavigator.com/news/gsk-acquires-license-for-rna-drug-discovery-platform/2024-06-18T12:06:00+00:00https://thepharmanavigator.com/news/gsk-acquires-promising-liver-disease-drug-in-usd-2-billion-deal/2025-05-19T14:16:36+00:00https://thepharmanavigator.com/news/gsk-and-vesalius-therapeutics-partner-to-advance-parkinsons-research/2024-12-03T11:38:00+00:00https://thepharmanavigator.com/news/gsk-demonstrates-advanced-phase-gonorrhea-success/2024-03-11T16:19:00+00:00https://thepharmanavigator.com/news/gsk-hengrui-pharma-partner-on-development-of-up-to-12-innovative-medicines/2025-07-31T09:02:30+00:00https://thepharmanavigator.com/news/gsk-ltz-therapeutics-collaborate-on-next-gen-immunotherapies/2025-11-25T16:16:00+00:00https://thepharmanavigator.com/news/gsk-names-ceo-designate-as-emma-walmsley-set-to-step-down/2025-09-30T15:48:00+00:00https://thepharmanavigator.com/news/gsk-partners-with-cttq-to-fast-track-bepirovirsen-launch-in-china/2026-05-15T09:09:46+00:00https://thepharmanavigator.com/news/gsk-set-to-acquire-nuvalent-in-multi-product-oncology-deal/2026-06-15T14:45:35+00:00https://thepharmanavigator.com/news/guest-blog-five-factors-affecting-cdmo-revenue-performance-and-five-ways-to-win/2025-09-16T14:21:00+00:00https://thepharmanavigator.com/news/halda-raises-126m-to-advance-novel-solid-tumor-therapies/2024-08-12T13:10:00+00:00https://thepharmanavigator.com/news/hovione-expands-cork-facility-boosts-spray-drying-capacity/2024-12-07T15:41:00+00:00https://thepharmanavigator.com/news/how-cdmos-are-driving-the-adoption-of-continuous-biomanufacturing/2025-03-18T11:46:00+00:00https://thepharmanavigator.com/news/how-cdmos-will-shape-pharma-in-2025-and-beyond/2024-12-15T08:09:00+00:00https://thepharmanavigator.com/news/how-demand-for-flexibility-is-shaping-facilities-of-the-future/2025-04-16T07:26:00+00:00https://thepharmanavigator.com/news/how-europes-cdmos-are-adapting-to-market-dynamics/2025-01-07T07:37:00+00:00https://thepharmanavigator.com/news/how-impactful-are-adverse-weather-events-to-pharma-supply-chains/2024-10-11T08:34:00+00:00https://thepharmanavigator.com/news/humanetics-partners-with-lifecore-biomedical-to-advance-bio-300/2025-03-29T16:39:00+00:00https://thepharmanavigator.com/news/hvivo-secures-usd-25-mn-contract-for-hmpv-study/2025-03-02T10:53:00+00:00https://thepharmanavigator.com/news/ibios-29m-deal-with-astralbio-for-muscle-preserving-obesity-treatment/2025-01-15T09:38:00+00:00https://thepharmanavigator.com/news/iff-to-unveil-excipient-innovations-at-cphi-2024/2024-10-08T11:04:00+00:00https://thepharmanavigator.com/news/igc-pharma-progresses-towards-phase-1-alzheimers-clinical-trial/2024-02-19T09:08:00+00:00https://thepharmanavigator.com/news/illumina-nears-victory-in-ecj-appeal-over-grail-merger-and-eu-fine/2024-04-12T09:33:00+00:00https://thepharmanavigator.com/news/ima-group-sets-the-stage-for-interpack-2026/2026-04-29T14:50:37+00:00https://thepharmanavigator.com/news/in-developing-oral-treatments-complexity-is-the-new-normal/2025-02-04T16:25:55+00:00https://thepharmanavigator.com/news/independent-pathways-to-commercial-success-for-biotech-companies/2024-01-08T10:36:00+00:00https://thepharmanavigator.com/news/india-the-next-frontier-in-global-cdmo-services/2025-02-19T07:01:00+00:00https://thepharmanavigator.com/news/india-waives-local-clinical-trials-to-expedite-new-medicine-approval/2024-08-18T13:52:00+00:00https://thepharmanavigator.com/news/industry-keynote-daiichi-sankyo-and-adc-transformation/2024-01-06T09:28:00+00:00https://thepharmanavigator.com/news/industry-keynote-the-strategy-behind-tevas-new-era/2024-01-03T09:44:00+00:00https://thepharmanavigator.com/news/infinimmune-secures-funding-for-human-first-antibodies-targeting-atopic-dermatitis/2026-08-14T15:27:49+00:00https://thepharmanavigator.com/news/innovating-inhalation-the-future-of-pulmonary-and-nasal-drug-delivery/2025-12-03T19:18:16+00:00https://thepharmanavigator.com/news/integrating-sustainability-into-the-pharma-value-chain/2026-04-30T09:33:37+00:00https://thepharmanavigator.com/news/intercept-withdraws-liver-disease-drug-from-us-market/2025-09-12T15:27:45+00:00https://thepharmanavigator.com/news/interphex-2026-embedding-intelligence-into-bioprocessing/2026-04-15T11:51:43+00:00https://thepharmanavigator.com/news/interphex-2026-managing-data-integrity-in-a-multimodal-pipeline/2026-04-15T09:26:21+00:00https://thepharmanavigator.com/news/interphex-2026-the-continuous-conundrum/2026-04-14T15:42:27+00:00https://thepharmanavigator.com/news/interphex-2026-the-multimodal-future-of-sterile-manufacturing/2026-04-15T15:12:26+00:00https://thepharmanavigator.com/news/intertek-scales-capacity-for-complex-drug-stability-testing/2026-05-16T09:43:32+00:00https://thepharmanavigator.com/news/inventage-lab-acquires-40-stake-in-quratis-to-boost-mrna-capabilities/2025-02-17T11:01:00+00:00https://thepharmanavigator.com/news/investing-in-innovation-to-capture-next-gen-therapy-potential/2025-08-29T09:22:00+00:00https://thepharmanavigator.com/news/iqvia-global-trends-in-randd-2024-report/2024-03-08T11:51:00+00:00https://thepharmanavigator.com/news/is-2024-the-year-for-resurgence-in-the-biotech-sector/2024-04-02T10:02:00+00:00https://thepharmanavigator.com/news/is-cannabis-legislation-a-promising-sign-for-pharmaceutical-cannabinoids/2024-03-08T14:31:00+00:00https://thepharmanavigator.com/news/is-north-americas-hold-on-the-biologics-cdmo-market-at-risk/2025-02-05T08:46:00+00:00https://thepharmanavigator.com/news/is-pharma-innovation-in-europe-falling-behind-the-us-and-china/2024-05-06T13:34:00+00:00https://thepharmanavigator.com/news/ita-group-acquires-uk-based-c2events-to-bolster-global-pharma-event-capabilities/2025-12-10T11:23:00+00:00https://thepharmanavigator.com/news/jandj-sues-ex-employee-over-alleged-theft-of-trade-secrets-for-pfizer/2024-04-07T10:02:00+00:00https://thepharmanavigator.com/news/jandj-sues-samsung-bioepis-over-biosimilar-breach/2025-03-16T12:02:00+00:00https://thepharmanavigator.com/news/jandj-to-acquire-shockwave-medical-for-131-billion-boosting-cardiovascular-medtech-division/2024-04-20T13:41:00+00:00https://thepharmanavigator.com/news/janux-therapeutics-value-increases-upon-trial-results/2024-03-14T09:21:00+00:00https://thepharmanavigator.com/news/jasper-therapeutics-completes-acquisition-of-kira-pharmaceuticals/2026-08-02T17:30:10+00:00https://thepharmanavigator.com/news/jim-petrilla-joins-vernal-biosciences-as-ceo/2024-11-08T13:40:00+00:00https://thepharmanavigator.com/news/joinn-biologics-acquires-lonzas-guangzhou-facility-to-expand-asia-pacific-presence/2025-02-08T09:27:00+00:00https://thepharmanavigator.com/news/joint-venture-between-bioduro-and-cenra-set-to-increase-commercial-api-manufacturing-capacity/2026-03-05T09:57:31+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-a-cloud-based-future-for-regulatory-submissions/2026-01-07T09:05:00+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-finding-a-winning-strategy/2026-01-07T12:49:00+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-from-speculative-hype-to-operational-high-conviction/2026-01-05T10:04:00+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-investing-in-domestic-resilience/2026-01-09T16:05:56+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-mastering-operational-improvements/2026-01-06T16:52:17+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-navigating-new-therapeutic-frontiers/2026-01-12T09:23:21+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-targeting-a-competitive-future/2026-01-08T11:07:22+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-the-great-biopharma-reset/2026-01-07T15:26:00+00:00https://thepharmanavigator.com/news/jp-morgan-healthcare-conference-2026-the-practical-economic-value-of-ai/2026-01-12T13:50:53+00:00https://thepharmanavigator.com/news/judo-bio-launches-with-100-million-and-new-ceo/2024-10-18T14:33:00+00:00https://thepharmanavigator.com/news/key-insights-from-cdmo-trends-in-oral-solid-dosage/2024-09-14T09:04:00+00:00https://thepharmanavigator.com/news/kindeva-expands-uk-facilities/2024-06-15T04:59:00+00:00https://thepharmanavigator.com/news/korsch-unveils-compact-high-speed-rotary-tablet-press-at-interpack-2026/2026-05-13T10:47:25+00:00https://thepharmanavigator.com/news/kpmg-life-sciences-ceo-outlook-report/2024-12-13T09:53:00+00:00https://thepharmanavigator.com/news/kpmg-releases-life-sciences-ceo-outlook-report/2024-03-19T10:04:00+00:00https://thepharmanavigator.com/news/lanova-medicines-secures-42-million-in-funding-to-accelerate-oncology-innovations/2024-10-26T11:24:00+00:00https://thepharmanavigator.com/news/lantern-pharma-progresses-novel-adc-initiative-in-various-solid-cancer-types/2024-03-04T10:43:00+00:00https://thepharmanavigator.com/news/lantheus-acquires-evergreen-theragnostics-to-strengthen-radiopharmaceutical-leadership/2025-02-13T10:54:00+00:00https://thepharmanavigator.com/news/laurus-labs-expands-product-portfolio-boosts-cdmo-capabilities/2024-11-06T11:53:16+00:00https://thepharmanavigator.com/news/lb-bohle-to-showcase-continuous-manufacturing-tech-at-interphex-2026/2026-04-10T10:09:17+00:00https://thepharmanavigator.com/news/lexarias-glp-1-study-shows-promising-8-week-weight-loss-results/2024-09-02T13:46:00+00:00https://thepharmanavigator.com/news/lifecore-and-indomo-sign-new-deal-to-develop-drugdevice-combination-acne-treatment/2026-03-13T09:28:11+00:00https://thepharmanavigator.com/news/lifecore-biomedical-expands-to-target-glp-1-injectables-and-big-pharma/2025-02-28T10:13:00+00:00https://thepharmanavigator.com/news/lifecore-biomedical-partners-with-nirsum-labs-to-advance-addiction-treatment/2025-01-18T10:07:00+00:00https://thepharmanavigator.com/news/lilly-agrees-to-buy-three-vaccine-developers-in-infectious-disease-deal/2026-06-01T13:41:47+00:00https://thepharmanavigator.com/news/lilly-and-haya-join-forces-for-breakthrough-metabolic-treatments/2024-09-18T09:34:00+00:00https://thepharmanavigator.com/news/lilly-cuts-price-of-tirzepatide-single-dose-vials-to-increase-patient-affordability/2025-12-05T17:15:00+00:00https://thepharmanavigator.com/news/lilly-expedites-injectable-medicine-production-through-facility-acquisition/2024-05-03T13:57:00+00:00https://thepharmanavigator.com/news/lilly-grows-european-manufacturing-capacity-with-new-facility-in-the-netherlands/2025-11-06T17:33:17+00:00https://thepharmanavigator.com/news/lilly-increases-investment-at-indiana-site-to-9billion-to-boost-api-production-for-weight-loss-and-diabetes/2024-06-05T16:11:00+00:00https://thepharmanavigator.com/news/lilly-looks-to-ai-in-fight-against-drug-resistant-bacteria/2024-07-09T12:46:00+00:00https://thepharmanavigator.com/news/lilly-reinforces-chinese-market-commitment-amidst-us-china-biotech-tensions/2024-04-08T09:10:00+00:00https://thepharmanavigator.com/news/lilly-to-acquire-merida-biosciences-for-antibody-degradation-technology/2026-09-04T10:39:13+00:00https://thepharmanavigator.com/news/lillys-legal-action-to-protect-weight-loss-drugs/2025-01-14T09:08:00+00:00https://thepharmanavigator.com/news/lonza-announces-closure-of-chinese-plant/2024-02-13T11:15:00+00:00https://thepharmanavigator.com/news/lonza-drops-chi-business-to-focus-on-cdmo-services/2024-12-16T08:19:00+00:00https://thepharmanavigator.com/news/lonza-expands-microbial-manufacturing-to-meet-biotech-demand/2024-09-13T09:19:00+00:00https://thepharmanavigator.com/news/lonza-expands-swiss-bioconjugation-facilities-to-meet-rising-demand/2024-11-21T10:04:00+00:00https://thepharmanavigator.com/news/lonza-gets-swissmedic-nod-for-new-aseptic-drug-product-filling-line/2025-10-09T14:46:00+00:00https://thepharmanavigator.com/news/lonza-group-welcomes-new-ceo/2024-07-15T08:08:00+00:00https://thepharmanavigator.com/news/lonza-launches-media-development-lab-to-optimize-media-formulations/2026-04-05T15:25:58+00:00https://thepharmanavigator.com/news/lonza-sees-strong-cdmo-demand-and-projects-20-sales-growth-for-2025/2025-02-05T09:15:00+00:00https://thepharmanavigator.com/news/lonza-strengthens-advanced-synthesis-offering/2026-02-25T16:17:13+00:00https://thepharmanavigator.com/news/lonza-targets-bloodbrain-barrier-challenge-with-nona-biosciences-deal/2026-07-14T15:16:14+00:00https://thepharmanavigator.com/news/lonzas-12-billion-deal-demonstrates-demand-for-cdmo-capabilities/2024-04-06T10:25:00+00:00https://thepharmanavigator.com/news/losing-the-competitive-edge/2025-09-17T13:25:36+00:00https://thepharmanavigator.com/news/lotte-biologics-and-merck-kgaa-partner-to-boost-biopharma-production/2024-06-17T07:26:00+00:00https://thepharmanavigator.com/news/lotte-biologics-to-invest-3-billion-in-songdo-biomanufacturing-expansion/2024-07-18T09:33:00+00:00https://thepharmanavigator.com/news/lotte-biologics-unveils-dual-cdmo-strategy-in-us-and-korea/2025-01-29T10:04:00+00:00https://thepharmanavigator.com/news/lotte-group-restructures-bio-division-focuses-on-cdmo-growth/2024-09-08T08:39:00+00:00https://thepharmanavigator.com/news/lsd-treatment-receives-breakthrough-therapy-status-for-anxiety/2024-03-25T09:54:00+00:00https://thepharmanavigator.com/news/lupin-appoints-ceo-of-new-api-cdmo-subsidiary/2024-07-01T06:47:00+00:00https://thepharmanavigator.com/news/lyocontract-and-syntegon-break-ground-on-freeze-drying-facility-in-germany/2026-03-20T12:32:25+00:00https://thepharmanavigator.com/news/magnet-biomedicine-and-eli-lilly-partner-to-develop-molecular-glue-medicines/2025-03-09T11:23:00+00:00https://thepharmanavigator.com/news/making-the-right-capacity-decisions-at-the-biomanufacturing-crossroads/2025-09-02T10:18:00+00:00https://thepharmanavigator.com/news/mandm-to-address-packaging-trends-and-solutions/2024-09-23T12:07:00+00:00https://thepharmanavigator.com/news/manufacturing-conglomerate-jabil-establishes-cdmo-presence/2025-02-22T08:06:00+00:00https://thepharmanavigator.com/news/matchpoint-novartis-collaborate-on-oral-inhibitors-for-inflammatory-diseases/2025-07-28T08:54:57+00:00https://thepharmanavigator.com/news/matica-bio-and-kalivir-partner-to-advance-oncolytic-virus-manufacturing-for-cancer-therapies/2024-11-18T14:54:00+00:00https://thepharmanavigator.com/news/matica-secures-multiple-viral-vector-cdmo-contracts/2024-11-04T14:05:00+00:00https://thepharmanavigator.com/news/measuring-more-of-what-matters/2026-02-27T11:57:02+00:00https://thepharmanavigator.com/news/medpharm-and-tergus-pharma-merge-to-form-topical-and-transepithelial-cdmo/2024-07-19T10:58:00+00:00https://thepharmanavigator.com/news/medpharm-gains-olink-certification-to-introduce-proteomic-analysis-services/2026-08-27T13:52:37+00:00https://thepharmanavigator.com/news/medpharm-strengthens-manufacturing-capabilities-with-successful-fda-inspection/2026-01-11T17:22:34+00:00https://thepharmanavigator.com/news/meeting-modern-needs-top-insights-from-drug-development-and-delivery-insights-for-2025-day/2025-07-14T14:55:00+00:00https://thepharmanavigator.com/news/meeting-new-manufacturing-demands-by-investing-in-flexibility/2025-11-19T15:09:00+00:00https://thepharmanavigator.com/news/meeting-new-needs-the-key-trends-shaping-oral-dosage-formulation/2025-07-18T09:25:00+00:00https://thepharmanavigator.com/news/merck-acquires-b-cell-depletion-therapy-from-curon-biopharmaceutical/2024-08-14T13:27:00+00:00https://thepharmanavigator.com/news/merck-acquisition-provides-boost-to-gene-therapy-capabilities/2024-06-07T07:23:00+00:00https://thepharmanavigator.com/news/merck-enters-definitive-agreement-to-acquire-springworks-therapeutics/2025-05-01T10:10:07+00:00https://thepharmanavigator.com/news/merck-faces-keytruda-price-cuts-under-ira-by-2028/2025-03-14T11:51:00+00:00https://thepharmanavigator.com/news/mercks-2-billion-deal-with-hansoh-for-oral-obesity-drug/2025-01-17T09:57:00+00:00https://thepharmanavigator.com/news/metavia-syntekabio-partner-up-to-expand-therapeutic-potential-of-oral-gpr119-agonist/2025-08-05T14:44:17+00:00https://thepharmanavigator.com/news/metsera-secures-usd-215-million-to-advance-obesity-treatments-and-glp-1-drug-development/2024-12-01T10:47:00+00:00https://thepharmanavigator.com/news/mhra-fast-tracks-approval-of-new-xgeva-formulation-via-international-recognition-procedure/2024-03-22T10:00:00+00:00https://thepharmanavigator.com/news/mhra-unveils-new-guidance-to-accelerate-assessment-of-established-medicines/2024-03-21T17:00:00+00:00https://thepharmanavigator.com/news/milliporesigma-invests-76-mn-to-triple-adc-production-capacity/2024-11-12T14:16:00+00:00https://thepharmanavigator.com/news/mitigating-potential-contamination-through-risk-based-formulation/2025-07-07T14:10:13+00:00https://thepharmanavigator.com/news/moderna-broadens-horizon-with-promising-trials-for-new-vaccines/2024-04-16T10:12:00+00:00https://thepharmanavigator.com/news/moderna-gains-fda-approval-for-new-coronavirus-vaccine/2025-06-05T08:20:38+00:00https://thepharmanavigator.com/news/moderna-secures-us-government-grant-for-avian-influenza-vaccine-development/2025-02-02T11:00:00+00:00https://thepharmanavigator.com/news/moderna-signs-licensing-deal-with-nanexa-to-explore-long-acting-injectable-formulations/2025-12-19T13:04:06+00:00https://thepharmanavigator.com/news/modernizing-generic-and-biosimilar-formulation/2026-05-14T11:00:49+00:00https://thepharmanavigator.com/news/monte-rosa-novartis-target-undruggable-proteins-in-major-immunology-partnership/2025-09-18T18:54:00+00:00https://thepharmanavigator.com/news/more-job-layoffs-announced/2024-03-31T10:47:00+00:00https://thepharmanavigator.com/news/mri-technique-detects-bioluminescence-in-the-brain/2024-05-25T09:13:00+00:00https://thepharmanavigator.com/news/mundipharma-and-vectura-to-develop-environment-friendly-flutiform-inhaler/2024-05-02T11:37:00+00:00https://thepharmanavigator.com/news/nanoform-and-plusvitech-collaborate-to-repurpose-aprepitant-for-lung-cancer-treatment/2024-04-26T12:39:00+00:00https://thepharmanavigator.com/news/nanoform-and-takeda-showcase-advances-in-biologic-drug-delivery-at-ddf-summit/2025-09-19T14:01:33+00:00https://thepharmanavigator.com/news/nanoform-announces-promising-clinical-results-for-nanoenzalutamide/2024-02-09T09:57:00+00:00https://thepharmanavigator.com/news/nanoform-celanese-expand-collaboration-to-advance-long-acting-biologics/2024-10-04T10:30:00+00:00https://thepharmanavigator.com/news/nanoform-collaborate-on-takedas-plasma-derived-therapy-development/2024-08-23T15:49:00+00:00https://thepharmanavigator.com/news/nanoform-commenced-relative-bioavailability-study-of-nanotechnology-enhanced-enzalutamide/2024-01-29T11:32:00+00:00https://thepharmanavigator.com/news/nanoform-completed-new-share-issue-to-raise-165-mn/2024-05-05T11:17:00+00:00https://thepharmanavigator.com/news/nanoform-establishes-new-company-and-outlicenses-nanoformulation-of-encorafenib/2025-10-17T18:33:00+00:00https://thepharmanavigator.com/news/nanoform-receives-funding-to-advance-clinical-development-of-nanoapalutamide/2025-06-23T13:58:09+00:00https://thepharmanavigator.com/news/nanoform-secures-european-commercial-cgmp-manufacturing-license/2025-11-21T11:21:21+00:00https://thepharmanavigator.com/news/nanoform-wins-business-finland-grant-for-its-randd-in-nanoparticle-enabled-formulation/2024-03-04T13:52:00+00:00https://thepharmanavigator.com/news/national-resilience-confirms-layoffs-amid-expansion-and-leadership-change/2024-12-23T10:36:00+00:00https://thepharmanavigator.com/news/navigating-industry-challenges-with-renewed-optimism/2025-06-26T07:40:00+00:00https://thepharmanavigator.com/news/navigating-the-hot-topics-for-biopharma/2025-04-17T10:25:00+00:00https://thepharmanavigator.com/news/navigating-the-next-era-of-rna-manufacturing/2026-07-29T10:47:57+00:00https://thepharmanavigator.com/news/navigating-the-strategic-imperatives-of-dcat-week-2026/2026-03-19T11:30:57+00:00https://thepharmanavigator.com/news/nec-and-agc-biologics-partner-to-advance-personalized-oral-cancer-vaccine/2024-08-19T14:02:00+00:00https://thepharmanavigator.com/news/neurobo-announces-successful-pre-clinical-results/2024-07-05T05:02:00+00:00https://thepharmanavigator.com/news/new-analysis-strengthens-evidence-of-reduced-risk-of-dementia-with-shingles-vaccination/2025-04-04T13:49:47+00:00https://thepharmanavigator.com/news/new-data-demonstrates-unique-expression-profile-of-rna-platform/2025-05-19T10:38:22+00:00https://thepharmanavigator.com/news/new-joint-regulatory-plan-to-streamline-biotechnology-oversight/2024-06-03T14:02:00+00:00https://thepharmanavigator.com/news/new-strategic-investment-set-to-speed-up-growth-for-pci/2025-07-15T13:28:51+00:00https://thepharmanavigator.com/news/new-us-tariffs-on-branded-and-patented-drugs-announced/2025-09-26T19:03:21+00:00https://thepharmanavigator.com/news/noflu-consortium-awarded-contract-worth-up-to-eur-148-million/2026-03-02T14:31:38+00:00https://thepharmanavigator.com/news/non-opioid-drugs-show-promise-in-a-new-generation-of-pain-management-therapies/2024-02-23T15:46:00+00:00https://thepharmanavigator.com/news/northstar-medical-radioisotopes-opens-new-radiopharmaceutical-cdmo-facility/2024-11-13T14:20:00+00:00https://thepharmanavigator.com/news/novartis-announces-closure-of-its-san-diego-research-facility/2024-07-22T12:42:00+00:00https://thepharmanavigator.com/news/novartis-invests-in-end-to-end-manufacturing-in-us/2025-11-24T11:22:17+00:00https://thepharmanavigator.com/news/novartis-is-expanding-its-us-manufacturing-and-rampd-presence/2025-04-10T07:47:00+00:00https://thepharmanavigator.com/news/novartis-opens-viral-vector-production-facility-in-slovenia/2025-02-27T09:44:00+00:00https://thepharmanavigator.com/news/novartis-prepares-pluvicto-filing-for-earlier-prostate-cancer-stages-based-on-new-survival-data/2024-04-23T10:09:00+00:00https://thepharmanavigator.com/news/novartis-rare-kidney-disease-candidate-gains-positive-eu-committee-opinion/2025-03-07T11:20:00+00:00https://thepharmanavigator.com/news/novartis-set-to-expand-antibody-production-in-singapore/2024-04-01T08:54:00+00:00https://thepharmanavigator.com/news/novartis-surpasses-q1-expectations-raises-full-year-outlook-on-strong-drug-sales/2024-05-05T08:08:00+00:00https://thepharmanavigator.com/news/novartis-to-acquire-anthos-therapeutics-in-usd-925-million-deal/2025-02-23T08:23:00+00:00https://thepharmanavigator.com/news/novavaxs-covid-19-jab-gets-fda-approval/2025-05-23T13:38:00+00:00https://thepharmanavigator.com/news/novo-holdings-completes-165-billion-acquisition-of-catalent/2025-01-08T08:06:00+00:00https://thepharmanavigator.com/news/novo-holdings-eyes-expansion-of-catalent-amid-us-policy-shifts/2025-02-24T08:52:00+00:00https://thepharmanavigator.com/news/novo-holdings-plans-to-double-catalents-size-amid-us-manufacturing-focus/2025-01-27T09:38:00+00:00https://thepharmanavigator.com/news/novo-holdings-receives-eu-approval-for-catalent-acquisition/2024-12-21T10:04:00+00:00https://thepharmanavigator.com/news/novo-nordisk-acquires-cardior-pharmaceuticals-to-boost-cardiovascular-pipeline/2024-04-09T08:57:00+00:00https://thepharmanavigator.com/news/novo-nordisk-ceo-steps-down/2025-05-21T14:28:00+00:00https://thepharmanavigator.com/news/novo-nordisk-enters-146-billion-agreement-for-molecular-glue-treatments-development/2024-03-14T14:34:00+00:00https://thepharmanavigator.com/news/novo-nordisk-launches-worlds-first-oral-glp-1/2026-01-09T10:09:58+00:00https://thepharmanavigator.com/news/novo-nordisk-outlines-strategy-2030-plan-for-catalent-acquisition-future-focus/2024-03-28T10:20:00+00:00https://thepharmanavigator.com/news/novo-nordisk-reveals-headline-phase-iii-trial-results-evaluating-combination-obesity-treatment/2026-02-03T16:40:09+00:00https://thepharmanavigator.com/news/novo-nordisk-secures-approval-in-china-for-obesity-drug-wegovy/2024-07-03T12:26:00+00:00https://thepharmanavigator.com/news/novo-nordisk-secures-exclusive-rights-to-lexicons-lx9851/2025-04-02T09:34:22+00:00https://thepharmanavigator.com/news/novo-nordisk-to-halt-human-insulin-pen-production/2024-11-20T09:44:00+00:00https://thepharmanavigator.com/news/novo-nordisks-wegovy-approved-by-the-fda-for-heart-attack-and-stroke-prevention/2024-03-24T14:58:00+00:00https://thepharmanavigator.com/news/novo-plans-to-acquire-cdmo-catalent/2024-02-20T10:47:00+00:00https://thepharmanavigator.com/news/novo-refiles-165-bn-catalent-acquisition-to-extend-ftc-review-period/2024-04-26T08:54:00+00:00https://thepharmanavigator.com/news/novo-unveils-transformation-plans-to-better-compete-in-the-obesity-market/2025-09-12T11:31:16+00:00https://thepharmanavigator.com/news/novos-monlunabant-shows-side-effects-in-phase-2-trial/2024-09-24T08:44:00+00:00https://thepharmanavigator.com/news/nvidia-invests-35-million-into-biotech-technology-company/2024-03-30T13:49:00+00:00https://thepharmanavigator.com/news/omniabio-opens-new-facility-in-canada-to-advance-cell-and-gene-therapy-manufacturing/2024-10-30T13:49:00+00:00https://thepharmanavigator.com/news/onesource-expands-glp-1-drug-device-capacity/2024-12-17T08:32:00+00:00https://thepharmanavigator.com/news/ongoing-investment-the-key-to-next-gen-therapy-progress/2025-08-28T12:55:00+00:00https://thepharmanavigator.com/news/onkure-completes-merger-with-reneo-pharmaceuticals-and-raises-65-million/2024-10-20T14:37:00+00:00https://thepharmanavigator.com/news/opening-the-door-the-technology-scaling-the-next-era-of-emerging-therapies/2026-03-12T12:47:48+00:00https://thepharmanavigator.com/news/ophthalmic-gel-shows-promising-results-for-geographic-atrophy-treatment/2025-02-11T10:48:00+00:00https://thepharmanavigator.com/news/optimizing-biomanufacturing-with-digital-tools/2025-08-22T13:17:00+00:00https://thepharmanavigator.com/news/orchestrating-decentralized-biomanufacturing/2026-09-03T09:36:35+00:00https://thepharmanavigator.com/news/otsuka-and-icu-medical-partner-to-enhance-north-american-iv-solutions-supply/2024-11-24T10:20:00+00:00https://thepharmanavigator.com/news/overcoming-brand-loyalty-survey-suggests-a-challenge-for-generic-drugs/2024-04-24T13:54:00+00:00https://thepharmanavigator.com/news/overcoming-the-hurdles-to-oral-peptide-development/2026-07-22T14:33:10+00:00https://thepharmanavigator.com/news/oxford-biomedica-rebrands-as-oxb/2024-09-26T09:37:43+00:00https://thepharmanavigator.com/news/pace-acquires-catalents-north-carolina-laboratory/2024-10-03T10:26:45+00:00https://thepharmanavigator.com/news/panel-a-look-at-biopharma-manda-and-shifting-deal-dynamics/2024-01-05T10:30:00+00:00https://thepharmanavigator.com/news/panel-getting-your-molecule-thru-the-clinic-a-view-from-partners-c-suite/2024-01-12T10:46:00+00:00https://thepharmanavigator.com/news/partnership-forms-for-the-development-of-inhaled-antiviral-treatments/2026-04-04T09:22:30+00:00https://thepharmanavigator.com/news/partnership-forms-to-advance-oral-macrocyclic-peptide-therapies-for-immunological-diseases/2025-11-27T12:20:00+00:00https://thepharmanavigator.com/news/partnership-forms-to-develop-broad-spectrum-ntm-clinical-candidate/2025-07-04T09:09:21+00:00https://thepharmanavigator.com/news/partnership-set-up-to-address-growing-demand-for-self-administered-therapies/2026-01-23T15:12:05+00:00https://thepharmanavigator.com/news/pathios-therapeutics-raises-bms-led-series-b-funding/2024-05-03T08:54:00+00:00https://thepharmanavigator.com/news/pci-expands-us-fillfinish-capabilities-with-althea-acquisition/2025-04-28T14:26:29+00:00https://thepharmanavigator.com/news/pci-pharma-services-invests-365-million-to-expand-global-drug-delivery-and-device-capabilities/2024-10-05T10:35:00+00:00https://thepharmanavigator.com/news/pci-pharma-services-unveils-major-expansion/2026-05-04T10:00:26+00:00https://thepharmanavigator.com/news/pfizer-and-astellas-feature-in-super-bowl-commercials/2024-02-27T10:48:00+00:00https://thepharmanavigator.com/news/pfizer-and-az-announce-significant-stake-in-french-economy/2024-05-23T10:15:00+00:00https://thepharmanavigator.com/news/pfizer-launches-their-alternative-to-lillydirect/2024-05-15T13:53:00+00:00https://thepharmanavigator.com/news/pfizers-cachexia-drug-shows-positive-results-in-mid-stage-trials/2024-09-26T09:42:32+00:00https://thepharmanavigator.com/news/pharmaceutical-industry-deals-hit-decade-low-in-2024/2024-12-05T15:25:00+00:00https://thepharmanavigator.com/news/pharmalogic-strengthens-footing-in-radiopharmaceutical-field-with-acquisition/2025-04-11T08:02:00+00:00https://thepharmanavigator.com/news/pharmapack-2026-a-new-era-of-accountable-pharma-packaging/2026-01-14T21:36:38+00:00https://thepharmanavigator.com/news/pharmapack-2026-moving-toward-a-large-volume-future/2026-01-15T09:06:00+00:00https://thepharmanavigator.com/news/pharmapack-2026-solving-the-intradermal-delivery-puzzle/2026-01-14T08:57:19+00:00https://thepharmanavigator.com/news/pharmapack-2026-the-importance-of-early-integration/2026-01-13T14:34:32+00:00https://thepharmanavigator.com/news/phillips-medisize-to-acquire-vectura-expanding-inhalation-drug-delivery-capabilities/2024-09-25T09:13:00+00:00https://thepharmanavigator.com/news/piramal-pharma-commits-85-million-for-capacity-expansion-and-growth/2024-11-14T14:23:00+00:00https://thepharmanavigator.com/news/porton-advanced-and-eureka-therapeutics-partner-to-accelerate-t-cell-therapy-development/2025-04-04T10:31:00+00:00https://thepharmanavigator.com/news/praxis-makes-strategic-acquisition-of-aci/2025-09-26T09:57:14+00:00https://thepharmanavigator.com/news/preclinical-data-demonstrates-therapeutic-efficacy-of-enverics-lead-candidate/2025-07-17T10:09:33+00:00https://thepharmanavigator.com/news/preclinical-study-finds-nanotrastuzumab-to-be-comparable-with-herceptin-hylecta/2026-02-13T12:31:46+00:00https://thepharmanavigator.com/news/predicting-accurately-to-de-risk-early-development/2026-02-11T15:07:57+00:00https://thepharmanavigator.com/news/private-equity-firms-acquire-biologics-cdmo-avid-bioservices/2024-11-27T10:31:00+00:00https://thepharmanavigator.com/news/prolific-machines-sets-new-mab-productivity-benchmark-at-21-gl/2026-05-06T14:12:46+00:00https://thepharmanavigator.com/news/putting-a-spotlight-on-formulation-services/2025-07-23T13:10:37+00:00https://thepharmanavigator.com/news/putting-clinical-trials-under-a-magnifying-glass/2026-05-20T07:00:00+00:00https://thepharmanavigator.com/news/realizing-the-reality-of-oral-biologics/2026-08-14T09:00:57+00:00https://thepharmanavigator.com/news/recipharm-and-exela-announce-strategic-alliance/2024-10-17T14:24:00+00:00https://thepharmanavigator.com/news/recipharm-unveils-advanced-aseptic-filling-system/2025-02-26T09:18:00+00:00https://thepharmanavigator.com/news/redx-pharma-clinical-trial-for-pioneering-crohns-disease-medication/2024-03-18T09:25:00+00:00https://thepharmanavigator.com/news/reflecting-a-broader-audience-cphi-americas-event-preview/2025-05-13T13:00:00+00:00https://thepharmanavigator.com/news/reflecting-on-a-transformative-event-for-the-americas-pharma-market/2025-05-28T23:05:08+00:00https://thepharmanavigator.com/news/regeneron-acquires-oxular-to-expand-ophthalmology-portfolio/2025-01-20T10:17:00+00:00https://thepharmanavigator.com/news/regeneron-and-mammoth-biosciences-forge-100m-gene-editing-collaboration/2024-05-05T14:36:00+00:00https://thepharmanavigator.com/news/regeneron-to-buy-bankrupt-dna-testing-firm/2025-05-22T09:31:00+00:00https://thepharmanavigator.com/news/regeneron-ventures-launches-500-million-fund-to-accelerate-life-sciences-innovation/2024-04-29T09:13:00+00:00https://thepharmanavigator.com/news/regenerons-multiple-myeloma-therapy-receives-eu-approval/2025-05-06T13:41:58+00:00https://thepharmanavigator.com/news/regulation-ai-and-supply-chain-resilience-to-take-centre-stage-at-cphi-americas-2026/2026-05-22T13:58:59+00:00https://thepharmanavigator.com/news/reinventing-gene-therapy/2025-08-06T09:21:00+00:00https://thepharmanavigator.com/news/rentschler-biopharma-realigns-strategy-to-focus-on-biologics/2025-02-09T09:57:00+00:00https://thepharmanavigator.com/news/rentschler-biopharma-to-build-state-of-the-art-buffer-media-station-in-laupheim/2024-11-11T14:12:00+00:00https://thepharmanavigator.com/news/rentschler-expands-production-capacity-amid-growing-cdmo-demand/2024-08-17T13:43:00+00:00https://thepharmanavigator.com/news/requiring-refinement-and-control-of-complexity-and-cost/2025-08-27T14:11:00+00:00https://thepharmanavigator.com/news/research-shows-that-aspirin-could-help-prevent-colon-cancer/2024-05-04T08:31:00+00:00https://thepharmanavigator.com/news/responding-to-demand-with-the-latest-service-offerings/2025-10-01T15:39:34+00:00https://thepharmanavigator.com/news/restructuring-efforts-see-rocket-focus-on-cardiovascular-programs/2025-07-29T09:19:55+00:00https://thepharmanavigator.com/news/rethinking-bioprocessing/2026-08-19T10:29:55+00:00https://thepharmanavigator.com/news/revival-in-us-biotech-financing-marks-end-of-two-year-slump/2024-03-06T10:38:00+00:00https://thepharmanavigator.com/news/rewriting-the-outsourcing-playbook/2026-06-11T10:45:26+00:00https://thepharmanavigator.com/news/rezdiffra-launches-as-first-mash-treatment-with-promising-rapid-uptakes/2024-04-25T13:18:00+00:00https://thepharmanavigator.com/news/rezon-bio-launches-as-european-biologics-cdmo/2025-10-02T09:59:00+00:00https://thepharmanavigator.com/news/rfk-in-the-cabinet-a-reformist-vision-or-threat-to-scientific-integrity/2024-11-25T10:23:00+00:00https://thepharmanavigator.com/news/riding-the-oral-glp-1-wave/2025-04-30T08:30:00+00:00https://thepharmanavigator.com/news/rilzabrutinib-gains-regulatory-nods-in-the-us-and-japan/2026-02-12T11:07:25+00:00https://thepharmanavigator.com/news/rising-rates-of-measles-is-highlighting-level-of-vaccine-misinformation/2025-06-04T11:50:57+00:00https://thepharmanavigator.com/news/rising-tides-and-biologics-growth-for-cdmos/2024-10-01T12:28:00+00:00https://thepharmanavigator.com/news/roche-accelerates-obesity-treatment-development-with-carmot-acquisition/2024-08-06T08:24:00+00:00https://thepharmanavigator.com/news/roche-acquires-poseida-therapeutics-boosting-cell-therapy-portfolio/2024-12-09T15:49:00+00:00https://thepharmanavigator.com/news/roche-commits-billions-to-strengthening-us-presence/2025-04-23T15:17:26+00:00https://thepharmanavigator.com/news/roche-earns-ce-mark-for-ai-enabled-medical-device/2024-07-24T07:55:00+00:00https://thepharmanavigator.com/news/roche-weighs-next-steps-for-astegolimab-after-mixed-copd-trial-results/2025-07-24T13:24:46+00:00https://thepharmanavigator.com/news/roches-pmn-therapy-meets-primary-endpoint-in-phase-iii-trial/2026-02-20T14:38:51+00:00https://thepharmanavigator.com/news/rovi-issues-profit-warning-amid-declining-cdmo-activity/2025-03-01T10:36:00+00:00https://thepharmanavigator.com/news/rovi-retains-cdmo-business-rejecting-5-offers-for-sale/2024-11-15T14:32:00+00:00https://thepharmanavigator.com/news/samabriva-expands-biomanufacturing-capabilities-with-new-belgian-facility/2024-12-27T11:02:00+00:00https://thepharmanavigator.com/news/samsung-biologics-bags-12b-contract-boosting-2024-value-to-over-33b/2024-11-07T12:00:00+00:00https://thepharmanavigator.com/news/samsung-biologics-becomes-first-korean-cdmo-to-join-us-nonprofit-group/2024-08-22T13:02:00+00:00https://thepharmanavigator.com/news/samsung-biologics-plans-sixth-manufacturing-plant/2025-01-30T10:44:00+00:00https://thepharmanavigator.com/news/samsung-biologics-record-quarter-driven-by-biosimilars-sales/2024-07-31T12:38:07+00:00https://thepharmanavigator.com/news/samsung-biologics-secures-1-06-billion-manufacturing-deal-with-us-pharma/2024-07-14T07:45:00+00:00https://thepharmanavigator.com/news/samsung-biologics-secures-record-usd-14-billion-contract-with-european-client/2025-02-03T11:04:00+00:00https://thepharmanavigator.com/news/sanner-acquires-gilero-to-expand-medical-device-offering/2024-09-22T08:33:00+00:00https://thepharmanavigator.com/news/sanner-enhancing-patient-friendly-packaging/2025-09-03T08:36:33+00:00https://thepharmanavigator.com/news/sanner-group-acquires-gilero-to-boost-global-medical-device/2024-10-04T10:33:00+00:00https://thepharmanavigator.com/news/sanner-group-announces-construction-milestone-at-new-headquarters-and-production-site/2023-10-25T10:55:00+00:00https://thepharmanavigator.com/news/sanner-group-strengthens-medical-device-capabilities-with-acquisition-of-springboard-pro/2024-01-26T10:59:00+00:00https://thepharmanavigator.com/news/sanner-group-to-showcase-expanded-global-cdmo-services-at-cphi-frankfurt/2025-09-24T13:42:00+00:00https://thepharmanavigator.com/news/sanner-launches-enhanced-packaging-for-tablets-and-capsules/2025-05-08T08:39:00+00:00https://thepharmanavigator.com/news/sanofi-and-novavax-agree-12-billion-vaccine-alliance/2024-05-19T09:33:00+00:00https://thepharmanavigator.com/news/sanofi-and-orano-partner-to-develop-next-generation-radioligand-cancer-therapies/2024-10-28T13:32:00+00:00https://thepharmanavigator.com/news/sanofi-and-owkin-intensify-ai-alliance-to-revolutionize-immunology-drug-development/2024-04-10T10:12:00+00:00https://thepharmanavigator.com/news/sanofi-enters-into-agreement-to-acquire-blueprint-medicines/2025-06-03T13:36:30+00:00https://thepharmanavigator.com/news/sanofi-teams-to-leverage-openai-and-formation-bio-to-boost-biopharma-randd/2024-06-04T15:29:00+00:00https://thepharmanavigator.com/news/sanofis-global-restructure-layoffs-and-randd-reprioritization-to-spearhead-immunoscience-focus/2024-04-22T13:25:00+00:00https://thepharmanavigator.com/news/sarepta-gains-recognition-from-fda-for-its-viral-vector-technology/2025-06-06T11:18:35+00:00https://thepharmanavigator.com/news/sartorius-and-sanofi-collaborate-on-bioprocess-intensification/2024-05-24T10:06:00+00:00https://thepharmanavigator.com/news/satatuote-support-sanofi-recycling-initiative/2023-09-12T09:56:00+00:00https://thepharmanavigator.com/news/schott-pharma-announces-innovative-cartridge-nesting-for-efficiency-and-sustainability/2024-12-28T11:06:00+00:00https://thepharmanavigator.com/news/schott-pharma-expands-glass-syringe-production-with-new-hungary-facility/2024-11-19T09:23:40+00:00https://thepharmanavigator.com/news/schott-pharma-expands-pharmaversity-with-launch-of-knowledge-hub/2025-07-25T20:45:12+00:00https://thepharmanavigator.com/news/schott-pharma-invests-371-million-in-new-us-facility-for-prefillable-syringe-production/2024-04-19T09:30:00+00:00https://thepharmanavigator.com/news/schott-pharma-opens-production-facility-in-hungary/2024-06-28T08:57:00+00:00https://thepharmanavigator.com/news/schott-pharma-unveils-next-generation-polymer-syringe-system/2025-01-24T08:56:00+00:00https://thepharmanavigator.com/news/schreiner-medipharms-innovative-label-enhances-wuxi-xdcs-clinical-trials/2024-12-08T15:43:00+00:00https://thepharmanavigator.com/news/scientists-discover-new-class-of-antibiotics-that-work-against-mdr-bacteria/2025-09-23T14:18:00+00:00https://thepharmanavigator.com/news/scinai-immunotherapeutics-establishes-us-cdmo-subsidiary/2025-01-13T09:05:00+00:00https://thepharmanavigator.com/news/scorpius-holdings-reports-16-revenue-growth-in-q2-2024/2024-09-01T13:42:00+00:00https://thepharmanavigator.com/news/scorpius-to-present-ways-to-optimize-cash/2024-10-03T10:28:00+00:00https://thepharmanavigator.com/news/sean-keveney-named-fdas-next-chief-counsel/2025-08-08T14:36:55+00:00https://thepharmanavigator.com/news/sekisui-diagnostics-expands-cgmp-biopharma-cdmo-capacity/2024-11-23T10:14:00+00:00https://thepharmanavigator.com/news/seran-doubles-us-clinical-manufacturing-capacity/2024-09-20T15:22:00+00:00https://thepharmanavigator.com/news/seran-secures-funding-to-offer-commercial-scale-cdmo-services/2024-09-29T10:44:00+00:00https://thepharmanavigator.com/news/servier-taps-insilicos-pharmaai-in-multi-billion-oncology-deal/2026-01-09T15:36:39+00:00https://thepharmanavigator.com/news/serving-as-a-gateway-to-the-americas-pharma-market/2025-06-13T11:16:58+00:00https://thepharmanavigator.com/news/sgs-strengthens-rsv-vaccine-research-with-launch-of-challenge-agent/2025-12-09T10:31:00+00:00https://thepharmanavigator.com/news/shapiro-administration-invests-nearly-3-million-to-bring-adarepharma-solutions-headquarters-to-pennsylvania/2024-08-10T09:28:00+00:00https://thepharmanavigator.com/news/sharp-services-expands-pennsylvania-facility/2024-06-13T04:17:00+00:00https://thepharmanavigator.com/news/shilpa-medicare-unveils-hybrid-cdmo-model-at-dcat-2025/2025-03-31T15:43:00+00:00https://thepharmanavigator.com/news/shl-medical-and-kindeva-partner-to-enhance-molly-autoinjector-platform/2025-04-06T10:41:00+00:00https://thepharmanavigator.com/news/simplifying-downstream-processing-for-complex-biologics/2026-05-11T15:52:48+00:00https://thepharmanavigator.com/news/simtra-commences-work-on-bloomington-facility-expansion/2024-06-20T14:05:00+00:00https://thepharmanavigator.com/news/sk-bioscience-acquires-idt-biologika-to-expand-global-cdmo-business/2024-10-14T13:42:00+00:00https://thepharmanavigator.com/news/sk-pharmteco-unifies-global-cdmo-brands-to-streamline-drug-development-services/2024-12-18T08:49:00+00:00https://thepharmanavigator.com/news/south-africans-take-on-pharmaceutical-company-vertex/2024-04-01T13:15:00+00:00https://thepharmanavigator.com/news/spectronrx-announces-collaboration-for-european-radiotherapy-isotope-manufacturing-facility/2024-11-02T13:59:00+00:00https://thepharmanavigator.com/news/spinout-ensorcell-launches-with-three-flagship-life-science-tools/2025-11-17T12:29:25+00:00https://thepharmanavigator.com/news/st-pharm-quantoom-biosciences-expand-collaboration-rna-manufacturing/2024-08-30T13:31:00+00:00https://thepharmanavigator.com/news/staying-ahead-in-a-dynamic-market-environment/2025-11-06T11:20:13+00:00https://thepharmanavigator.com/news/staying-ahead-of-regulatory-revisions/2025-09-17T17:55:00+00:00https://thepharmanavigator.com/news/steriline-to-showcase-advanced-robotic-vial-filling-and-capping-machine/2024-09-24T08:36:00+00:00https://thepharmanavigator.com/news/strategic-collaboration-forms-to-offer-companies-integrated-biopharmaceutical-solutions-nbsp/2025-12-08T20:34:00+00:00https://thepharmanavigator.com/news/study-reveals-many-fast-tracked-cancer-drugs-fail-to-show-long-term-benefits/2024-04-25T09:00:00+00:00https://thepharmanavigator.com/news/summit-therapeutics-partners-with-pfizer-to-evaluate-ivonescimab/2025-03-11T11:29:00+00:00https://thepharmanavigator.com/news/sun-pharma-agrees-all-cash-acquisition-of-organon/2026-05-01T12:39:56+00:00https://thepharmanavigator.com/news/superluminal-secures-120-million-to-boost-gpcr-drug-discovery/2024-09-10T09:07:00+00:00https://thepharmanavigator.com/news/suven-pharma-targets-usd-1-bn-revenue-by-2030/2025-04-05T10:34:00+00:00https://thepharmanavigator.com/news/syngene-opens-first-us-manufacturing-facility-to-expand-cdmo-services/2025-03-26T14:53:00+00:00https://thepharmanavigator.com/news/syntegon-expands-sepion-tablet-coater-series-with-pilot-scale-model/2026-08-28T10:16:07+00:00https://thepharmanavigator.com/news/syntegon-launches-new-filling-machine-for-rtu-syringes/2025-04-22T08:47:46+00:00https://thepharmanavigator.com/news/syntegon-unveils-new-aseptic-filling-line/2025-05-30T08:08:21+00:00https://thepharmanavigator.com/news/systematic-review-shows-no-evidence-of-link-between-acetaminophen-and-autism/2026-01-23T11:20:23+00:00https://thepharmanavigator.com/news/takeda-astellas-and-smbc-launch-strategic-alliance-for-drug-discovery/2024-05-04T11:34:00+00:00https://thepharmanavigator.com/news/takeda-restructures-cuts-early-stage-drug-programs/2024-05-21T10:02:00+00:00https://thepharmanavigator.com/news/tanvex-and-bora-forge-global-biologics-manufacturing-alliance/2024-09-09T08:54:00+00:00https://thepharmanavigator.com/news/tanvex-biopharma-completes-acquisition-of-bora-biologics/2025-01-23T08:31:00+00:00https://thepharmanavigator.com/news/ten23-health-dsm-firmenich-partner-to-expand-excipient-choices/2026-07-27T09:11:21+00:00https://thepharmanavigator.com/news/ten23-health-opens-new-office-in-tokyo/2026-04-20T15:33:46+00:00https://thepharmanavigator.com/news/ten23-health-validates-west-synchrony-s1-prefillable-syringe-platform/2026-05-08T11:31:43+00:00https://thepharmanavigator.com/news/terumo-expands-cdmo-production-capacity-with-european-acquisition/2025-10-06T18:38:00+00:00https://thepharmanavigator.com/news/terumo-launches-injection-filter-needle-as-part-of-infino-development-program/2025-01-21T07:37:00+00:00https://thepharmanavigator.com/news/terumo-launches-new-intradermal-injection-system/2025-07-02T13:37:51+00:00https://thepharmanavigator.com/news/terumo-launches-study-for-resorbable-microsphere-efficacy-in-liver-cancer-treatment/2024-04-18T16:05:00+00:00https://thepharmanavigator.com/news/terumo-medical-expands-manufacturing-in-puerto-rico/2024-04-18T11:24:00+00:00https://thepharmanavigator.com/news/terumos-ultimaster-stents-gain-mdr-approval/2025-03-19T11:53:00+00:00https://thepharmanavigator.com/news/teva-and-alvotech-set-to-transform-humira-market-with-simlandi-fda-approval/2024-05-02T09:01:14+00:00https://thepharmanavigator.com/news/teva-announces-it-will-divest-api-business-as-part-of-pivot-to-growth-strategy/2024-02-14T09:18:00+00:00https://thepharmanavigator.com/news/teva-to-launch-humira-biosimilar-amid-mixed-q1-results/2024-05-20T09:00:00+00:00https://thepharmanavigator.com/news/the-delicate-balance-between-innovation-and-execution/2026-02-19T12:00:29+00:00https://thepharmanavigator.com/news/the-green-biopharma-roadmap/2026-09-09T19:18:13+00:00https://thepharmanavigator.com/news/the-need-for-collaboration-to-ensure-excipient-availability-and-innovation/2026-02-04T19:16:31+00:00https://thepharmanavigator.com/news/the-need-for-innovation-in-the-excipient-toolkit/2026-05-21T10:30:05+00:00https://thepharmanavigator.com/news/the-outsourcing-pivot-for-biopharma-innovation/2026-01-16T17:03:21+00:00https://thepharmanavigator.com/news/the-pragmatic-ai-pivot/2026-07-06T10:00:08+00:00https://thepharmanavigator.com/news/the-rising-specialization-of-cdmos/2025-01-21T07:17:00+00:00https://thepharmanavigator.com/news/the-road-ahead-for-resilient-supply-chains/2025-09-08T15:47:50+00:00https://thepharmanavigator.com/news/the-role-of-artificial-intelligence-in-antibody-drug-discovery/2026-02-05T08:00:22+00:00https://thepharmanavigator.com/news/the-worlds-most-expensive-drug-offers-hope-for-mld-patients/2024-04-17T09:23:00+00:00https://thepharmanavigator.com/news/thermo-fisher-acquires-solventums-purification-and-filtration-business/2025-03-06T11:17:00+00:00https://thepharmanavigator.com/news/thermo-fisher-announces-further-job-losses/2025-02-10T10:42:00+00:00https://thepharmanavigator.com/news/thermo-fisher-anticipates-cdmo-growth-amid-industry-shifts/2025-01-25T09:09:00+00:00https://thepharmanavigator.com/news/thermo-fisher-invests-22-million-in-us-oral-solid-dose-capabilities/2024-10-05T10:43:00+00:00https://thepharmanavigator.com/news/thermo-fisher-opens-gmp-certified-ultra-cold-facility/2024-06-16T05:02:00+00:00https://thepharmanavigator.com/news/thermo-fisher-restructures-viral-vector-operations-with-160-layoffs/2024-11-20T09:37:00+00:00https://thepharmanavigator.com/news/thermo-fisher-scientific-unveils-co2-cell-therapy-incubators-for-automated-labs/2024-06-21T14:10:00+00:00https://thepharmanavigator.com/news/thermo-fisher-to-acquire-swedish-proteomics-firm/2024-07-23T05:58:00+00:00https://thepharmanavigator.com/news/thermo-to-acquire-sanofis-sterile-manufacturing-site-expanding-strategic-partnership/2025-07-25T10:21:25+00:00https://thepharmanavigator.com/news/thoughts-from-industry-experts-before-they-head-to-milan/2024-10-02T10:01:00+00:00https://thepharmanavigator.com/news/tierra-biosciences-completes-series-a-for-predictive-ai-protein-platform/2024-03-26T11:02:00+00:00https://thepharmanavigator.com/news/tipping-the-scales-the-benefits-of-continuous-bioprocessing/2026-04-02T10:18:36+00:00https://thepharmanavigator.com/news/tirzepatide-lowers-blood-pressure-of-obesity-patients/2024-02-21T14:31:00+00:00https://thepharmanavigator.com/news/tiziana-life-sciences-partners-with-renaissance-lakewood-to-advance-intranasal-foralumab/2025-03-10T11:26:00+00:00https://thepharmanavigator.com/news/touchlight-appoints-industry-veteran-will-downie-as-strategic-adviser/2025-02-12T10:50:00+00:00https://thepharmanavigator.com/news/touchlight-to-provide-gmp-dbdna-for-zika-study/2024-08-27T13:16:00+00:00https://thepharmanavigator.com/news/touchlights-cell-free-dna-platform-enters-first-in-human-cancer-trial/2026-08-04T14:19:02+00:00https://thepharmanavigator.com/news/tourmaline-bio-trials-promising-cardiovascular-therapy/2024-05-30T10:06:00+00:00https://thepharmanavigator.com/news/transforming-modern-drug-development-with-rwe/2026-02-26T11:47:25+00:00https://thepharmanavigator.com/news/transforming-the-treatment-landscape-with-tailored-therapies/2026-03-05T11:44:13+00:00https://thepharmanavigator.com/news/triastek-and-biontech-collaborate-on-3d-printed-rna-therapeutics/2024-08-05T15:54:00+00:00https://thepharmanavigator.com/news/trump-vs-harris-what-does-it-mean-for-biopharma/2024-10-23T11:08:00+00:00https://thepharmanavigator.com/news/tuhura-biosciences-completes-merger-with-kintara-therapeutics/2024-10-25T11:19:00+00:00https://thepharmanavigator.com/news/uk-cma-investigates-vifor-pharma-over-anti-competitive-pricing/2024-02-13T14:12:00+00:00https://thepharmanavigator.com/news/uk-regulator-introduces-sandbox-for-ai-as-a-medical-device-testing/2024-05-22T09:36:00+00:00https://thepharmanavigator.com/news/uk-to-ban-more-dangerous-drugs/2024-09-12T09:16:00+00:00https://thepharmanavigator.com/news/uks-labour-party-unveils-520-million-innovative-manufacturing-fund-in-life-science-heavy-budget/2024-11-10T13:54:00+00:00https://thepharmanavigator.com/news/uncovering-the-real-reasons-behind-drug-shortages/2024-06-10T03:28:00+00:00https://thepharmanavigator.com/news/univercells-and-repligen-collaborate-to-bring-real-time-pat-to-bioreactors/2025-07-10T15:15:00+00:00https://thepharmanavigator.com/news/unlocking-ais-potential-in-pharma/2024-01-04T10:30:00+00:00https://thepharmanavigator.com/news/unlocking-potential-in-pulmonary-and-nasal-drug-delivery/2026-03-03T08:47:35+00:00https://thepharmanavigator.com/news/unlocking-the-full-potential-of-combined-capabilities/2026-05-14T06:45:58+00:00https://thepharmanavigator.com/news/unlocking-the-potential-of-next-gen-therapies-with-advanced-technology/2025-06-04T18:07:00+00:00https://thepharmanavigator.com/news/unpacking-the-cost-of-biomanufacturing/2025-08-06T12:48:00+00:00https://thepharmanavigator.com/news/upperton-announces-sterile-drug-manufacturing-investment/2024-02-08T11:17:00+00:00https://thepharmanavigator.com/news/upperton-unveils-sterile-manufacturing-facility/2025-02-07T09:24:00+00:00https://thepharmanavigator.com/news/us-government-to-propose-significant-drug-price-cuts-under-medicare-negotiations/2024-02-12T11:51:00+00:00https://thepharmanavigator.com/news/valsynthese-celebrate-40th-anniversary/2023-10-18T09:12:00+00:00https://thepharmanavigator.com/news/vegan-and-ketogenic-diets-found-to-alter-the-immune-system/2024-02-15T11:23:00+00:00https://thepharmanavigator.com/news/verastem-gets-nod-from-fda-for-rare-ovarian-cancer-combo-therapy/2025-05-12T10:03:24+00:00https://thepharmanavigator.com/news/vernal-biosciences-launches-integrated-services-for-mrna-medicines/2024-10-13T10:09:00+00:00https://thepharmanavigator.com/news/vertex-terminates-liver-disease-gene-editing-collaboration-with-verve-therapeutics/2025-03-12T11:43:00+00:00https://thepharmanavigator.com/news/vetter-advances-new-us-site-and-upgrades-austrian-facility/2026-04-19T11:25:25+00:00https://thepharmanavigator.com/news/vetter-advances-next-generation-tamper-evident-syringe-closure-towards-launch/2026-01-22T14:05:24+00:00https://thepharmanavigator.com/news/vetter-breaks-ground-on-new-us-clinical-manufacturing-site/2025-07-03T09:58:14+00:00https://thepharmanavigator.com/news/vetter-commits-to-new-production-facility-in-germany/2026-02-08T10:29:03+00:00https://thepharmanavigator.com/news/vetter-completes-third-expansion-phase-of-visual-inspection-and-logistics-center/2025-03-27T16:31:00+00:00https://thepharmanavigator.com/news/vetter-pharma-expands-manufacturing-capacity/2024-06-14T04:43:00+00:00https://thepharmanavigator.com/news/viatris-generic-iron-sucrose-gains-fda-nod/2025-08-12T15:01:08+00:00https://thepharmanavigator.com/news/viking-therapeutics-advances-obesity-drug-to-phase-3-with-300m-clinical-program/2024-08-07T08:43:00+00:00https://thepharmanavigator.com/news/viking-therapeutics-obesity-drug-exceeds-competitors/2024-03-13T11:25:00+00:00https://thepharmanavigator.com/news/vxgi-joins-biomap-for-biopharma-manufacturing-preparedness/2024-08-31T13:34:00+00:00https://thepharmanavigator.com/news/weathering-headwinds-biopharmas-roadmap-for-success-in-2026/2026-01-22T10:00:00+00:00https://thepharmanavigator.com/news/weekly-hiv-pill-advances-toward-regulatory-submission/2026-06-15T10:38:30+00:00https://thepharmanavigator.com/news/wegovy-and-similar-weight-loss-drugs-explored-as-potential-treatment-for-heart-failure-in-diabetic-and-obese-patients/2024-04-27T12:36:00+00:00https://thepharmanavigator.com/news/weighing-up-the-value-of-next-gen-therapies/2025-08-25T15:06:00+00:00https://thepharmanavigator.com/news/what-happens-when-your-cdmo-partnership-goes-wrong/2025-04-02T09:16:57+00:00https://thepharmanavigator.com/news/what-is-the-cost-of-developing-biologic-drugs/2024-05-29T05:02:00+00:00https://thepharmanavigator.com/news/whats-next-in-mrna-after-covid-19/2024-04-18T09:40:00+00:00https://thepharmanavigator.com/news/wheeler-bio-raises-usd-35-mn-in-oversubscribed-series-a-funding/2025-04-03T09:45:00+00:00https://thepharmanavigator.com/news/will-pharma-companies-continue-to-adopt-orphan-drugs/2024-05-04T13:54:00+00:00https://thepharmanavigator.com/news/wilmington-pharmatech-expands-us-api-manufacturing-capacity/2026-03-27T15:30:26+00:00https://thepharmanavigator.com/news/wmfts-to-showcase-single-use-fluid-management-solutions/2024-10-09T11:07:00+00:00https://thepharmanavigator.com/news/working-holistically-a-new-partnership-model-for-biologics-supply/2025-04-17T09:04:00+00:00https://thepharmanavigator.com/news/wuxi-expand-bioprocessing-capacity/2024-06-12T04:07:00+00:00https://thepharmanavigator.com/news/wuxi-secures-new-us-contracts-despite-biosecurity-concerns/2024-08-28T13:23:00+00:00https://thepharmanavigator.com/news/wuxi-shares-surge-following-biosecure-acts-exclusion/2024-06-27T10:48:00+00:00https://thepharmanavigator.com/news/xenon-presents-clinical-and-regulatory-milestones-at-jp-morgan-healthcare-conference/2026-01-15T14:09:35+00:00https://thepharmanavigator.com/news/zealand-pharma-faces-second-fda-rejection-due-to-cdmo-inspection-issues/2024-11-03T14:02:00+00:00https://thepharmanavigator.com/news/zealand-pharma-raises-1-billion-to-develop-obesity-drugs/2024-07-04T02:42:00+00:00https://thepharmanavigator.com/news/zeno-health-obtains-25-million-in-series-c-investment/2024-03-18T14:02:00+00:00https://thepharmanavigator.com/news/moonwalk-biosciences-closes-oversubscribed-series-b-financing-round/2026-10-01T06:30:40+00:00https://thepharmanavigator.com/news/a-new-frontier-of-regulatory-operations/2026-10-01T06:30:45+00:00https://thepharmanavigator.com/news/northway-biotech-expands-cgmp-cell-based-manufacturing/2026-10-01T06:30:45+00:00https://thepharmanavigator.com/news/lifecore-biomedical-signs-major-commercial-site-transfer-deal/2026-10-01T06:00:49+00:00https://thepharmanavigator.com/news/building-a-value-driven-platform/2026-10-01T06:30:47+00:00https://thepharmanavigator.com/news/camizestrant-combination-for-metastatic-breast-cancer-gains-fda-approval/2026-10-01T06:30:47+00:00https://thepharmanavigator.com/news/finding-a-path-to-unified-cmc/2026-10-01T06:30:53+00:00https://thepharmanavigator.com/news/circio-raises-funds-to-advance-in-vivo-car-t-program/2026-10-01T06:30:53+00:00https://thepharmanavigator.com/news/roche-gets-nod-from-european-commission-for-susvimo/2026-10-01T06:30:54+00:00https://thepharmanavigator.com/news/deciphering-the-amt-designation-program/2026-10-01T06:30:55+00:00https://thepharmanavigator.com/news/novo-nordisk-secures-global-license-to-nanexas-ald-drug-delivery-platform/2026-10-01T06:30:55+00:00https://thepharmanavigator.com/news/codis-appoints-steven-facer-in-new-role-as-chief-commercial-officer/2026-10-01T06:30:56+00:00https://thepharmanavigator.com/news/nanoform-highlights-cess-benefits-versus-spray-dried-asds/2026-10-01T06:30:57+00:00https://thepharmanavigator.com/news/cphi-milan-2026-overcoming-formulation-barriers-in-lais/2026-10-01T06:31:01+00:00https://thepharmanavigator.com/news/cphi-milan-2026-balancing-viscosity-compliance-and-sustainability-in-fill-finish/2026-10-01T06:00:50+00:00https://thepharmanavigator.com/news/cphi-milan-2026-connecting-supply-chains-digital-innovations-and-sustainability/2026-10-01T06:47:48+00:00https://thepharmanavigator.com/news/lifecore-biomedical-agrees-major-commercial-site-transfer-deal/2026-09-13T11:34:30+00:00https://thepharmanavigator.com/news/cphi-milan-2026-balancing-viscosity-compliance-and-sustainability-in-fillfinish/2026-10-01T06:47:09+00:00